Next Article in Journal
The Therapeutic Potential of Gut-Microbiota-Derived Metabolite 4-Phenylbutyric Acid in Escherichia coli-Induced Colitis
Previous Article in Journal
The Novel H10N3 Avian Influenza Virus Triggers Lethal Cytokine Storm by Activating Multiple Forms of Programmed Cell Death in Mammalian Lungs
Previous Article in Special Issue
CRISPR/Cas9 Genome Editing in the Diamondback Moth: Current Progress, Challenges, and Prospects
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Structural Features of 5′ Untranslated Region in Translational Control of Eukaryotes

by
Elizaveta Razumova
1,
Aleksandr Makariuk
2,
Olga Dontsova
1,3,4,5,
Nikita Shepelev
1,4 and
Maria Rubtsova
1,4,*
1
Chemistry Department, Lomonosov Moscow State University, Moscow 119234, Russia
2
Department of Biology, Lomonosov Moscow State University, Moscow 119234, Russia
3
A.N.Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119234, Russia
4
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117437, Russia
5
Skolkovo Institute of Science and Technology, Center for Molecular and Cellular Biology, Moscow 121205, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(5), 1979; https://doi.org/10.3390/ijms26051979
Submission received: 31 January 2025 / Revised: 19 February 2025 / Accepted: 21 February 2025 / Published: 25 February 2025
(This article belongs to the Special Issue Recent Progress in Molecular Biology of RNA 2.0)

Abstract

:
Gene expression is a complex process regulated at multiple levels in eukaryotic cells. Translation frequently represents a pivotal step in the control of gene expression. Among the stages of translation, initiation is particularly important, as it governs ribosome recruitment and the efficiency of protein synthesis. The 5′ untranslated region (5′ UTR) of mRNA plays a key role in this process, often exhibiting a complicated and structured landscape. Numerous eukaryotic mRNAs possess long 5′ UTRs that contain diverse regulatory elements, including RNA secondary structures, specific nucleotide motifs, and chemical modifications. These structural features can independently modulate translation through their intrinsic properties or by serving as platforms for trans-acting factors such as RNA-binding proteins. The dynamic nature of 5′ UTR elements allows cells to fine-tune translation in response to environmental and cellular signals. Understanding these mechanisms is not only fundamental to molecular biology but also holds significant biomedical potential. Insights into 5′ UTR-mediated regulation could drive advancements in synthetic biology and mRNA-based targeted therapies. This review outlines the current knowledge of the structural elements of the 5′ UTR, the interplay between them, and their combined functional impact on translation.

Graphical Abstract

1. Introduction

Modern advances in molecular biology have unveiled the sophisticated nature of gene expression regulation within cells. Conventionally, the primary level of expression control in eukaryotes was presumed to be the transcriptional stage, which directed the majority of studies on transcriptional regulation. However, accumulating evidence indicates that the post-transcriptional stages frequently play a pivotal role in regulating gene expression. Among them, translation serves as the most significant post-transcriptional stage of expression regulation.
The regulation of eukaryotic translation predominantly occurs at the initiation stage. This process begins with the assembly of an initiation complex on the 5′ untranslated region of mRNA (5′ UTR). The 5′ UTR can harbor various complex RNA secondary structures, including hairpins, RNA quadruplexes, and pseudoknots, as well as the elements associated with non-canonical translation initiation mechanisms such as internal ribosome entry site (IRES). In addition, specific nucleotide sequences, including the terminal oligopyrimidine tract (TOP), upstream open reading frames (uORFs), and translation initiators of short 5′ UTRs (TISUs), play important roles. The regulatory complexity is further complicated by a variety of RNA modifications that also affect the efficiency of translation initiation.
The structural features of 5′ UTRs can act as independent regulators of translation due to their spatial configurations, or alternatively, to serve as a platform to attract trans-acting factors such as RNA-binding proteins. These structural elements possess a dynamic character that enables the cell to adapt to the translation processes in a flexible manner in response to external stimuli. Furthermore, the regulation at the translational level allows the cell to modulate gene expression more rapidly, as the transcription step is not required.
The present review summarizes current data on the structural elements of the 5′ untranslated region of mRNA, their influence on translation, and the interrelationships between them.

2. 5′ Untranslated Region in Translation Initiation

In most mature eukaryotic mRNAs, three functional regions can be identified: the 5′ untranslated region (5′ UTR) containing the 5′ cap, the coding region (CDS), and the polyadenylated 3′ untranslated region (3′ UTR). The sequences of eukaryotic 5′ UTRs have a high GC content relative to the average in mRNA, which may contribute to the formation of complex secondary structures [1]. The length of this region differs between organisms, with a median length ranging from 53 nucleotides in budding yeast to 218 nucleotides in humans [2]. However, it should be noted that the length of 5′ UTRs varies considerably even among transcripts from the same organism [2]. Notably, a positive correlation has been observed between the structural complexity of 5′ UTRs and gene significance [3]. It is also noteworthy that there are mRNAs with very short 5′ UTRs (12 nucleotides on average) that are translated without scanning with a special TISU regulatory element [4], as well as those completely lacking 5′ UTRs, such as mammalian mitochondrial mRNAs [5] and circular mRNAs. It should be clarified that each mRNA molecule is generally utilized in multiple rounds of translation, thereby determining the number of protein molecules produced. This phenomenon is referred to as translational heterogeneity, which can be either intergenic (mRNAs from different genes are translated differently) or intragenic (mRNAs from the same gene are translated differently within the same cell or in different tissues) [6]. Translational heterogeneity can be achieved by tuning the 5′UTR.
Canonical translation initiation (Figure 1) begins with “mRNA activation”, the key step of which is the formation of a closed mRNA structure [7]. In a simplified model, during this process, the complex of initiation factors eIF4 binds the 5′ cap and polyadenylated 3′ end of the mRNA. The eIF4E protein interacts directly with the 5′ cap and the PABP protein binds to the poly-A tail. The integration of these elements into a unified complex is facilitated by eIF4G, thereby forming the ring structure of the mRNA. The eIF4A helicase, which is required for unwinding mRNA secondary structures, also binds to the complex, and its activity is regulated by the eIF4B and eIF4H proteins. Consequently, the eIF4E, eIF4G, and eIF4A proteins collectively form the eIF4F complex, which plays a central role in the mRNA activation.
In parallel with these processes, the 43S preinitiation complex is formed. The small 40S subunit of the ribosome, which is released after the completion of a translation cycle, binds to eIF3, eIF1, and eIF1A. Concurrently, a ternary complex comprising eIF2, GTP, and the initiator Met-tRNAiMet is formed independently. These complexes, in combination with eIF5, form the interaction-ready 43S complex. Following this, the 43S complex binds to the activated mRNA by eIF3, assisted by eIF4F, forming the 48S complex. This complex then begins scanning the mRNA from the 5′ to 3′ end in search of the start codon. When the small subunit encounters the start codon in a favorable context, hydrolysis of GTP bound by eIF2 occurs, mediated by eIF5. Consequently, the large 60S subunit of the ribosome is attached to the small subunit by the GTPase eIF5B. This process is accompanied by the release of the initiation factors eIF1, eIF2, eIF3, and eIF5 and the hydrolysis of GTP bound to eIF5B, after which eIF1A and eIF5B also leave the complex. These processes result in the formation of a functional 80S ribosomal complex ready for translation elongation.
In addition to the well-established process of classical cap-dependent translation initiation, non-canonical mechanisms have been identified in eukaryotic cells that are activated when eIF4E-dependent translation is repressed, for example, under stress conditions (Figure 1). Structures such as internal ribosome entry sites (IRESs) and N6-methyladenosine (m6A) modification can recruit initiator factors and ribosomes independently of the 5′ cap. The cap-dependent translation can also be initiated by alternative initiator factors such as DAP5 and eIF3D [8]. A distinct mechanism is RAN (repeat-associated non-AUG), which initiates translation on GC-rich repeats [9]. This process occurs without an AUG start codon and leads to the accumulation of toxic proteins associated with neurodegenerative diseases. While the precise mechanism of RAN translation remains to be fully elucidated, the role of ribosome quality control proteins in mitigating the accumulation of its products has been identified, rendering them promising therapeutic targets [10,11].

3. Regulatory Sequences of 5′ Untranslated Region

3.1. Terminal Oligopyrimidine Tract (TOP)

The terminal oligopyrimidine tract (TOP) is a structure located immediately downstream of the m7G cap. In the classical TOP sequence, a cytidine residue is always present at position +1, followed by a continuous tract of 4-15 pyrimidines, followed by a GC-rich region [12]. Recent data show that the consensus TOP motif is shorter than previously thought and is 5′-CYYYYYY-3′ (where Y is C or U), and the sequence downstream is not important [13,14].
TOP is present in the mRNAs of all human ribosomal proteins and in several other genes encoding proteins directly related to translation (e.g., eIF3, eIF4A, eIF2, and PABP) [12]. The motif has also been identified in the mRNAs of proteins outside the translation apparatus (e.g., RACK1, HNRNPA1, nucleophosmin, NAP1L1, vimentin, TCTP, Tudor-SN, TATA Box-Binding Protein-Associated Factor 1D, and Galectin-1) [12,14,15], which may indicate their translation-associated function. It is noteworthy that numerous such transcripts are linked to oncogenesis [15,16,17,18,19,20,21,22]. In addition to the classical TOP, there are pyrimidine-rich translation elements (PRTEs) that undergo similar regulation to TOP [23]. The PRTE motif is defined by the presence of uridine at position 6 surrounded by pyrimidines (5′-YYYYYUYYY-3′), and its location is not immediately adjacent to the 5′ cap [23]. Currently, a transcript is categorized as a TOP based not only on its sequence but also on its relationship to translational regulation. Simplistic analysis of the terminal sequence reveals many more targets [24].
The TOP motif provides the selective regulation of gene translation depending on the energy and nutrient balance of the cell, mainly regulating components of protein biosynthesis [25]. In some cases, cooperative transcriptional and translational regulation is possible by switching between isoforms with different 5′ UTRs, which is important for tissue-specific expression and oncogenesis [13,26]. TOP regulation was initially hypothesized to be entirely dependent on the mTORC1 and PI3K pathways. However, subsequent studies have shown regulation independent of them [27,28,29], thus suggesting the involvement of a common trans-acting factor that integrates various cellular signals. Candidates for this role include S6K and rpS6, 4E-BP, La, LARP7, TIA-1/TIAR, CNBP/ZNF9, LARP1, miR-10a/miR-10b, and AUF1 [12,30]. However, the most compelling evidence has been obtained for the LARP1 protein. Interestingly, mRNAs that contain TOP are also susceptible to cytoplasmic recapping, a process that occurs in the cytoplasm subsequent to the partial degradation of the mRNA 5′ end [31]. Moreover, it has been observed that the position of recapping can be located downstream of the native site, thereby rendering the transcript immune to TOP regulation.
The model of TOP motif regulation through LARP1, as proposed in 2020 (Figure 2) [30], has been corroborated by a number of studies. The La-module of LARP1 binds the polyadenylated tail of mRNA and PABP independently of mTORC1, and its DM15 domain, activated by dephosphorylation, blocks the assembly of the initiation complex through interaction with the TOP motif, thereby suppressing the translation of mRNA from TOP under nutrient deficiency [32]. In addition, eIF4A1 enhances the interaction between LARP1 and TOP, promoting translational repression [33]. It is also noteworthy that LARP1 possesses a number of regulatory functions unrelated to translation initiation. For instance, LARP1 regulates the length of polyadenylated tails through interaction with non-canonical poly(A) polymerases in response to amino acid starvation, with transcripts with longer poly(A) tails being preferentially translated [34,35]. It is important to note that LARP1 also affects the stability of TOP mRNA [36,37], forming complexes with TOP mRNA and the free 40S subunit of the ribosome, thus controlling the homeostasis of the translation apparatus [38,39,40]. Recent data on the yeast homolog of LARP1, Slr1p, indicate the universal nature of these regulatory mechanisms in eukaryotes [41].

3.2. Upstream Small Open Reading Frames (uORFs) and Start Codons

Other elements of 5′ UTRs that play a role in the regulation of translation in eukaryotes are upstream open reading frames (uORFs) (Figure 3). Typically, uORFs are short sequences (up to 300 nucleotides long) located between the start and stop codons. If the stop codon of the uORF is within the main coding region, such uORFs are classified as overlapping uORFs. The median length of uORFs is 60 nucleotides, though some are considerably shorter. Additionally, the 5′ UTR can contain regulatory elements consisting of only a start and a stop codon. These elements are distinguished from uORFs by the absence of the translation elongation step.
It is well established that the recognition of the start codon is dependent on the surrounding nucleotide sequence. The optimal consensus for translation initiation in eukaryotes is G−6C−5C−4(A/G)−3C−2C−1A+1U+2G+3G+4, with the purine base at position −3 playing a key role [42]. In a strong context, the AUG codon of uORF takes over part of the scanning ribosomes, thereby suppressing the translation of the main ORF (CDS). By contrast, the “leaky scanning” of the AUG by the 48S complex is possible in a weak context, which reduces the inhibitory effect of the uORF. Translation initiation can also occur at non-canonical start codons (CUG, GUG, UUG, etc.), but with significantly lower efficiency. Initiation factors are responsible for recognizing the strength of the nucleotide context of the start codon by the ribosome. eIF1 provides a more stringent selection, while eIF5 promotes initiation at codons with suboptimal contexts. Interestingly, the translation of these factors is regulated by uORFs [43]. Apart from uORFs, start codons located in the 5′ UTR and in the same reading frame as the main ORF can be used to produce alternative proteoforms of the protein, thereby altering the protein functionality [44,45,46].
Currently, the main tool for detecting uORFs is ribosomal profiling, which relies on the deep sequencing of small mRNA fragments protected by ribosomes from nucleases [47]. Depending on the compound used to stall the ribosome, the method can identify regions of the mRNA that contain elongating or initiating ribosomes. In addition, high-throughput full-genome screens based on the CRISPR/Cas9 system are used to select functional uORFs [48]. However, the studies conducted to date have primarily focused on the search for micropeptides and have not been used to study regulatory uORFs. Given the substantial accumulation of ribosomal profiling and peptidomics data, the current studies are directed toward the systematization and standardization of the annotation of all small open reading frames (ORFs), including uORFs, across diverse organisms [49,50,51,52]. This endeavor incorporates considerations of conservation, disease association, and other relevant factors.
Regulatory uORFs are frequently observed in the genes associated with cell differentiation, translation, oncogenesis, and stress response [43,53,54,55]. The conserved nature of many uORFs among mammals indicates their important role in the regulation of key processes whose disruption can lead to severe disease [56].
The length of the regulatory uORF affects its function: shorter uORFs minimize the loss of initiator factors to the ribosome that can be used in the reinitiation of translation [57,58]. The distance from the stop codon of the uORF to the start codon of the CDS is also critical: a longer distance increases the time to attract eIF2, which is required for methionyl-tRNA binding to the ribosome [57]. It is well established that under stress conditions, the phosphorylation of eIF2 leads to the formation of a stable complex of phosphorylated eIF2 with the GTP exchange factor eIF2B [59], which reduces the availability of the ternary complex (TC), thereby promoting the translation of the CDS of some mRNAs, for example, ATF4 [60,61]. Under conditions of abundant TC, the overlapping mammalian ATF4 uORF suppresses the translation of the CDS; in contrast, when TC is deficient, the scanning complex initiates translation at the CDS by skipping the overlapping uORF [62]. Recent evidence suggests that a hairpin located at the overlap of the uORF and the CDS of ATF4 may also be involved in controlling ATF4 translation [63]. The authors hypothesize that the hairpin may induce the formation of a queue of preinitiation complexes after the start codon of the CDS, thereby facilitating initiation at the start codon of the uORF. At the same time, the hairpin may also lead to the translation initiation of the CDS at the non-canonical CUG start codon located after the AUG [63].
Actually, the secondary structures of 5′ UTRs, including G-quadruplexes and hairpins, impede ribosome scanning, thereby mitigating leaky scanning and enhancing translation initiation at inhibitory uORFs [63,64,65]. Experiments by M. Kozak demonstrated that introducing a hairpin downstream of a weak start codon stimulates translation initiation [66]. Furthermore, the interaction of uORF with 5′ UTR elements has been observed to modify the 5′ UTR structure. For example, in the case of the arginine/lysine transporter cat-1, it has been shown that the translation of uORF presumably promotes the formation of an active IRES [67].
The inhibitory properties of uORF can be enhanced not only by increasing its length but also by altering its nucleotide sequence, including rare codons that slow down ribosomes [68]. For example, a recent study showed that the uORF inhibitory properties of the yeast transcription factor, known as Yap1, were found to be abolished by the expression of a rare codon tRNA [69]. Ribosome arrest can also be induced by encoded amino acid motifs. It is known that to overcome polyproline motifs, the ribosome requires the factor eIF5A with an important post-translational modification—the inclusion of the non-canonical amino acid hypusine, the precursor of which is the polyamine spermidine [70]. At the same time, polyamines compete with eIF5A for association with ribosomes, providing a negative feedback loop [71]. The 5′ UTR of the AZIN1 gene transcript, an activator of amine biosynthesis, contains an uORF with a conserved PPW motif [72]. When polyamines are in excess, eIF5A is unable to bind to the ribosome and assist it in overcoming the complex motif, resulting in the ribosome queue formed on the uORF and inhibiting translation of the CDS.
In addition, the translation of S-adenosylmethionine decarboxylase (AMD1) [73] mRNA is also modulated by polyamine levels via the uORF encoding the MAGDIS peptide [74,75]. AMD1 is involved in the regulation of spermidine biosynthesis. An increased level of polyamines has been demonstrated to result in the arrest of ribosomes in the proximity of the uORF terminal codon [76]. This phenomenon has been shown to inhibit the translation of the CDS [76]. It is hypothesized that polyamines may influence the interaction between the forming MAGDIS and the ribosome [77]. A similar mechanism has been observed for the translation of arginine-attenuator peptide (AAP) in Neurospora crassa and Saccharomyces cerevisiae [78]. The presence of arginine leads to a change in the conformation of this peptide in the ribosome tunnel and translation termination [79], which may contribute to the nonsense-mediated decay (NMD) of mRNA [80]. Other studies have also reported a possible relationship between NMD and the CDS in the 5′ UTR; nevertheless, the observed mRNA degradation may be due to other mechanisms [81,82]. It is interesting to note that in plants, uORFs frequently serve as metabolite sensors for a broad array of compounds, including sucrose, phosphocholine, ascorbate, thermospermine, galactinol, and others [83]. This suggests the intriguing possibility that numerous other sensor uORFs may be present in human cells.
Apart from their regulatory function, certain mRNAs encode functional micropeptides that modulate the activity of the CDS product or assume a role that is independent of it. For example, the CDS in the 5′ UTR of protein kinase C mRNA encodes a micropeptide uPEP2 (26 a.a.) possessing a pseudosubstrate motif [84]. Due to it, this micropeptide is capable of inhibiting not only the product of the CDS but also protein kinases belonging to other families. Another example is the micropeptide ASDURF, a subunit of the PAQosome chaperone complex [85], which is translated from the uORF of the ASNSD1 gene and is required for medulloblastoma cell proliferation independently of the function of the ASNSD1 protein [86].
Numerous examples of the involvement of uORFs in translation leave no doubt about their importance as the regulatory elements of 5′ UTRs. Despite the large number of annotated uORFs, the detailed mechanisms of translation control involving them are poorly understood. The multistage and multifactorial nature of translation poses a significant challenge to the identification of all the possible regulatory pathways. Even the well-established model of the ATF4 translation regulation continues to be supplemented with new details. Despite the necessity for further research, the contemporary applications of data on uORFs already extend to biotechnology, especially plant engineering [87,88,89,90], and facilitate the explanation of the genetic basis of a number of human diseases [91].

4. RNA Structures Form Regulatory Elements in the 5′ Untranslated Region

4.1. RNA Secondary Structures: Stem-Loops and Pseudoknots

Intuitively, GC-rich 5′ UTRs should be capable of forming multiple stable structures such as hairpins (stem-loops) and pseudoknots. As discussed above, a hairpin downstream of the start codon can promote translation by increasing the time for AUG recognition by the ribosome, as in the case of ATF4 [63]. Conversely, the presence of a stabilized hairpin may result in translation repression, as observed in the iron-responsive element (IRE) located in the 5′ UTR of ferritin [92,93]. This hairpin serves as the binding site for the iron-regulatory proteins IRP1/2, which stabilize it under iron-deficient conditions. It is noteworthy that hairpins have been observed to regulate non-canonical cap-dependent translation by binding eIF3 directly. The deletion of the binding site in the mRNA examples described, JUN and BTG1, results in the opposite effect on translation [94,95].
It is generally accepted that the prevalence of intricate secondary structures in 5′ UTRs impedes conventional cap-dependent translation by obstructing ribosomal scanning. However, a recent study employing mutagenesis revealed that the complex structure of the 5′ UTR of SERPINA1 mRNA, contrary to the prevailing concept, promotes cap-dependent translation rather than inhibits it [96].
Translation can also be modulated by a pseudoknot, as evidenced by the observation that the translation of human IFN-γ mRNA containing a pseudoknot in the 5′ UTR is regulated through a protein kinase R (PKR) feedback loop [97]. IFN-γ activates PKR via the pseudoknot, resulting in the increased phosphorylation of eIF2α and decreased IFN-γ translation (Figure 4C). Despite the great potential of 5′ UTRs in the context of regulatory hairpin and pseudoknot formation [98], the number of detailed examples described is currently limited.

4.2. Riboswitches

Riboswitches are defined as structured RNA regions located in 5′ UTRs that regulate gene expression through the selective binding of different ligands [99]. In eukaryotic organisms, only a few examples of such structures have been described in chlorophytes and ascomycetes, all of which belong to the class of riboswitches sensitive to thiaminpyrophosphate, vitamin B1 [100]. These structures regulate splicing by altering the accessibility of splicing sites, depending on the amount of ligand, by changing the RNA structure. These structures were first described more than 10 years ago, and since then the discovery of alternative classes of riboswitches in eukaryotes has not been reported. Nevertheless, there is evidence for the existence of ligand-dependent regulatory structures in yeast 5′ UTRs. Specifically, studies have demonstrated that the 5′ UTRs of the sam1 and spe2 genes of S. pombe contain RNA structures that undergo conformational changes in response to ligand binding (SAM and spermidine, respectively), thereby regulating translation [101,102]. However, these findings require further validation.
The scarcity of extensive data on eukaryotic riboswitches may be partly due to the underdeveloped methodology for finding riboswitches in eukaryotic organisms. However, if this type of regulation is indeed less characteristic of eukaryotes and especially humans, a number of possibilities emerge. Firstly, a variety of riboswitches are widely distributed in bacterial genomes, where they regulate the expression of metabolite-associated genes [103]. They are currently being considered as potential targets for drug development to combat infections [104]. Secondly, the potential for the creation of various riboswitch-based regulated systems is introduced, which can be utilized for research purposes, the construction of viral constructs for transgene delivery, and synthetic biology [105,106,107,108].

4.3. G-Quadruplexes (rG4)

RNA G-quadruplexes (rG4s) are a class of extremely stable structures formed by guanine-rich sequences. rG4 consists of flat tetrads of four guanines linked together by Hoogsteen base pairs (Figure 4A). These tetrads form a negatively charged carbonyl oxygen center that coordinates positively charged cations, particularly K+, NH4+, and Na+. The cations K+ and NH4+ are large, and their location between the two tetrads stabilizes the quadruplex, in contrast to the relatively small Na+, which is embedded in the middle of one tetrad. Despite the fact that the existence of rG4 was demonstrated as early as 1991 in vitro [109], their presence and functionality in living cells remains a subject of debate, as the majority of studies have been conducted on synthetic oligonucleotides.
The classical sequence potentially forming rG4 has the following motif: GX-N1-7-GX-N(1-7)-GXN(1-7)-GX, where x is 3-6 nucleotides and N corresponds to any nucleotide (A, G, C, T, or U in the case of RNA). However, the current approaches also include the analysis of non-canonical rG4 in silico (Figure 4A). These are characterized by the presence of loops, bulges, the absence of some guanines, or the presence of only two tetrads [110,111,112]. Such non-canonical structures have been shown to dominate the transcriptome [110]. The distinguishing feature of rG4 from DNA quadruplexes is its increased stability due to the substitution of thymine for uracil and ribose in the sugar phosphate backbone. It is notable that these structural features also constrain the topology of rG4, restricting it to a predominantly parallel conformation, where all four strands are oriented in the same direction [113].
A wide range of methods are currently employed to detect G-quadruplex RNA, including modern high-throughput methods, such as rG4-seq, Keth-seq, SHALiPE, RT-stop, G4RP-seq, and others [114]. These methods provide the means to identify rG4 at the level of the entire transcriptome. The abundance of information has allowed the creation of databases dedicated to rG4 [112,115,116]. Experimental evidence has indicated that rG4 is enriched in the non-coding regions of mRNA, thus implying its significant functional role in the regulation of cellular processes [110], including transcription, mRNA maturation, and translational control [117]. The current data from high-throughput assays suggest that the rG4 found in vitro are predominantly unfolded in eukaryotic cells [118]. However, it cannot be excluded that most of them are dynamic structures, which mediate the active regulation of gene expression in response to changing conditions, as discussed in a recent review [119].
Detailed studies of rG4 are performed in vitro using synthetic oligonucleotides by physicochemical methods such as circular dichroism, UV spectroscopy, and NMR in the presence of stabilizing and destabilizing factors (metal ions, ligands, and aptamers) [114], and by chemical or enzymatic probing [114]. The development of a specific antibody BG4 was an important step in demonstrating the existence of rG4 in vivo [120]. However, the immunocytochemistry method has limitations because cell permeabilization can induce the formation of quadruplexes [113]. For this reason, organic chemistry efforts are currently focused on designing ligands that can be used to observe rG4 dynamics in a living cell [121,122,123,124,125,126,127,128]. Recent advances in method development also allow the use of NMR spectroscopy to study rG4 in vivo [129].
The effect of rG4 on translation is mainly studied using reporter constructs [130,131,132,133,134,135,136,137]. However, these approaches must be used with caution, as mutagenesis to destabilize rG4 can lead to changes in RNA structure, potentially impacting other regulatory regions in 5′ UTRs. This, in turn, can lead to either the inhibition or activation of translation. Intuitively, it is clear that stable rG4 located upstream of the open reading frame can interfere with ribosome movement and inhibit translation. This has been demonstrated using reporter constructs for multiple genes: NRAS [131], TERF2 [132], ATR [133], BCL2 [134], ADAM10 [135], CCND3 [136], MMP16 [137], and NRXN2 [130]. Moreover, using the 5′ UTR proto-oncogene NRAS as an example, it has been shown that this effect depends on the position and stability of rG4 [138]. The greatest effect is exerted by rG4, which is located closer to the 5′ cap and contains a large number of tetrads [138].
At the same time, in some cases, rG4 can promote translation. Most authors attribute the observed examples to cap-independent translation mediated by IRES. The rG4 are either directly part of the IRES structure or repress cap-dependent translation, thereby promoting IRES-mediated translation (discussed in detail in [139]). An example of rG4 located in the IRES structure is the quadruplex of the 5′ UTR of the VEGF gene [140]. Using footprinting, it was shown that rG4 located in the putative IRES of VEGF directly recruits the 40S subunit of the ribosome, thereby promoting cap-independent translation.
In addition, it has been reported that rG4 can stimulate translation independently of an IRES. For instance, one study suggests that the disruption of rG4, which is located near the 5′ cap of the cellular inhibitor of apoptosis protein cIAP1, significantly reduces translation levels [141]. Studies focusing on TGF-β2 gene have found that two quadruplexes in the 5′ UTR cooperatively enhance translation by an unknown mechanism [142,143]. Further studies are needed to understand the mechanisms of these effects, especially in the context of their association (or lack thereof) with IRES.
It is worth noting that rG4 can cooperate with other structures to affect canonical and cap-independent translation in different ways. For example, rG4, located near the cap in the 5′ UTR of the BAG-1 gene, suppresses cap-dependent translation by creating a structural obstacle for the ribosome. However, the rG4 simultaneously promotes IRES-mediated translation because its absence causes a change in the structure of the IRES located 300 nucleotides downstream [144].
The regulation of translation by rG4 in 5′ UTRs has been shown for various organisms: rG4 affects gene expression in malaria plasmodium, humans, and plants [65,145,146]. In addition, rG4 is commonly found in the 5′ UTRs of certain groups of genes, indicating a likely co-regulation of their expression. For example, rG4 has been shown to be enriched in the 5′ UTR mRNAs of ribosomal proteins in the GC-rich region following TOP, and their translation is regulated by specific helicases [147].
A number of helicases, such as DHX36, DHX9, DDX21, DDX2 (eIF4A), MOV10/L, and nucleic acid binding proteins, CNBP and hnRNP H/F, are known to bind and unfold rG4 [116,148,149,150]. For example, the DHX36 helicase is enriched in mRNA regions with rG4 and promotes quadruplex unfolding and translation. Under normal conditions, the expression level of DHX36 is low, but under certain conditions, such as the proliferation of skeletal muscle stem cells, it is upregulated, activating the translation of a group of genes that have rG4 in the 5′ UTR [151]. Later, the same authors showed that in the ANP32E gene, rG4 unwinding is promoted by the long non-coding RNA Lockd, which stabilizes the interaction between DHX36 and eIF3B [152]. High-throughput methods have confirmed the presence of rG4 downstream of multiple uORFs, where it promotes translation of these uORFs when DHX9 and DHX36 helicases are deficient [65]. Using fluorescent probes in vivo, rG4 has been shown to regulate ADAR translation in a DHX36-dependent manner [153]. Ribosome footprinting revealed eIF4A-mediated translational control of the rG4-containing transcripts of oncogenes [154].
rG4 in 5′ UTRs represent promising targets for therapy. Mutations that destabilize rG4 are associated with a number of diseases [155,156,157,158,159,160]. The development of targeted drugs that stabilize or destabilize the functional quadruplex, such as conjugates with aptamers [161] or small molecules [162], may allow the regulation of target gene expression. The fundamental possibility of this has been shown for the KRAS [163] and NRAS proto-oncogenes [164]. In addition, the role of rG4 in the stress response has been discussed in the literature [165]. In particular, a recent study reported that rG4 in the 5′ UTR of the FEN1 gene may act as a sensor of reactive oxygen species by regulating the expression of this gene [166].

4.4. IRES

Another example of a structure that regulates translation is the internal ribosome entry site (IRES). These structures were originally found in viruses. They promote ribosome recruitment and the subsequent translation in a cap- and 5′ UTR-independent manner. Viral IRESs have been the subject of significant research, and their structures in complex with the ribosome have been thoroughly characterized. They are actively used in biotechnology to create polycistronic mRNAs for expression in eukaryotic cells [167].
However, the existence of “genuine” cellular IRES is still a matter of debate despite many publications and even the creation of cellular IRES databases [168]. The fact is that most of the data that are currently available have been obtained using methods that can lead to a large number of artifacts and, as a consequence, to false positive results. For example, when using DNA-based bicistronic reporters, the translation product of an alternative mRNA transcribed from a putative promoter hidden within the putative IRES is taken as the signal from the IRES-mediated translation product. Recently, a group of researchers published a detailed guide on how to use dual reporter systems and what controls are necessary to avoid such errors [169]. In addition, there is some terminological confusion between IRES and CITE (cap-independent translation enhancer) [170]. It is important to note that while many studies equate cap-independent translation with IRES-mediated translation, this is not correct. The difference is that the IRES directly provides ribosome assembly and promotes scanless translation, whereas CITE requires the 5′ UTR [170]. Therefore, even experiments that confirm the presence of cap-independent translation of a transcript do not prove the presence of IRES.
To date, several principal mechanisms of IRES regulation have been identified (Figure 4E). It is hypothesized that IRES can be regulated by ITAF (IRES trans-acting factors) and the aforementioned rG4 and uORFs. ITAFs are proteins or regulatory RNAs that change the conformation of the IRES in response to conditions, generally serving an activating function [171]. ITAFs are suggested to play an important role in the cell’s coordinated response to stress [171]. rG4 may be an important structural element of IRES that determines its activity, in particular by directly binding the ribosome, as has been shown for VEGF [139,140]. In addition, rG4 at the 5′ end of the BAG1 gene has been reported to promote cap-independent translation, although it is not part of IRES. The authors posit that this rG4 may be crucial for stabilizing the IRES structure by recruiting ITAF [144]. uORFs may have the opposite effect on IRES-mediated cap-independent translation. As previously discussed, the translation of an uORF, as part of the IRES structure in cat-1 mRNA, changes the secondary structure to form an active IRES [172]. In contrast, the translation of uORFs within the IRES structure of VEGF suppresses its activity, as does the upstream IRES uORF in the FGF9 gene [173,174]. Previously, it was assumed that the IRESs could be regulated by TIE (translation inhibition element) and attract specialized ribosomes in HOXA9 [2,175]. However, a recent publication disputes the presence of IRES in HOXA9 [176].
Current evidence suggests that IRES can integrate signals from various cis- and trans-acting factors, thereby mediating complex translational regulation. However, due to a number of methodological issues, the findings on cellular IRESs should be interpreted with caution. Nevertheless, the abundant evidence of the importance of genome regions containing putative IRESs highlights the need for a detailed study of these structures. It cannot be excluded that these regions may in fact represent CITEs or other regulators of translation or transcription, a possibility which does not diminish their scientific value.

5. Modifications of mRNA

Previously, multiple nucleotide modifications were thought to be characteristic of non-coding transcripts. However, recent data indicate a wide variety of mRNA modifications (Figure 5) [177]. In addition to the well-established methylation of the N7-position of guanosine at the 5′ end of mRNA, the development of methods has enabled the identification of modifications such as m6A, m6Am, m1A, ac4C, pseudouridine, m5C, inosine, and internal m7G in all the regions of mRNA. They have different functions depending on location and affect mRNA processing, stability, localization, and translation. These modifications are dynamically regulated by three classes of enzymes: writers, readers, and erasers [177].
One of the most significant structural elements of mRNA is the 5′ cap. This is a co-transcriptional modification of mRNA, during which m7G is added to the 5′ end, attached via a 5′-5′-triphosphate bond, forming “cap 0”. In higher eukaryotes, the nucleotide following the cap is methylated at the 2′-O position to form “cap 1”. This modification is crucial for distinguishing between host and foreign RNA [178]. In addition, a subset of vertebrate mRNAs has either m6A or 2′-O-dimethyladenosine (m6Am) as the first nucleotide. In higher eukaryotes, the second nucleotide also undergoes ribose methylation, forming “cap 2”. It is noteworthy that alternative complex caps derived from metabolites such as NAD have been observed, but their function remains to be fully elucidated [179]. Accumulated evidence suggests a variety of mechanisms of capping, in particular, cytoplasmic re-capping [178]. In addition to the recruitment of initiator factors and the protection of mRNA from degradation, the cap and modifications to the 5′ end of mRNA may serve as a platform for interaction with a number of RNA-binding proteins involved in translation regulation. It has been determined that there are internal m7G sites that are enriched in the 5′ UTR near the translation initiation site, which are conserved among mammals [180,181].
N6,2′-O-dimethyladenosine (m6Am) is a modified nucleotide following the cap in many mammalian mRNAs. Research findings concerning the effect of this modification on translation are contradictory. The available evidence suggests that the effect may be tissue and cell type-specific, and may also depend on the methylation of the nucleotide following it [182]. It is also noteworthy that a number of methods for mapping m6A and m6Am fail to distinguish between these modifications. For instance, it has been demonstrated that a number of m6Am sites following the cap have been erroneously annotated as internal due to alternative transcription start sites [183].
The most extensively studied mRNA modification is m6A, which is uniformly distributed throughout its length and is particularly enriched around the stop codon [177]. This modification plays a critical role in the regulation of mRNA splicing, stability, localization, and translation [184]. It has been demonstrated to promote cap-independent translation. Specifically, m6A can bind directly to eIF3 [185,186], engaging the 43S initiator complex, or mediate translation through reader proteins such as YTHDF3 [187]. The mechanism of translation initiation via m6A has been proposed as a model for the translation of circular RNAs [188]. It is noteworthy that the dynamic regulation of translation mediated by m6A contributes to the cell’s complex and adaptive response to stress [189].
Another mRNA modification, N1-methyladenosine (m1A), is an isomer of m6A in which the nitrogen atom at position N1 instead of N6 is methylated. m1A is able to alter base pairing in RNA, turning the Watson–Crick pair into a Hoogsteen pair [190], potentially disrupting RNA secondary structure. Data show that m1A is enriched in 5′ UTR cytoplasmic mRNAs, mainly at the translation initiation site [191,192]. Additionally, reports indicate that m1A nucleotides are enriched near alternative translation initiation sites and are found at positions +1 and +2 relative to the cap [193,194]. Moreover, m1A in 5′ UTRs has been shown to be positively correlated with translation efficiency [179,182]. It is acknowledged that m1A in 5′ UTRs is dynamically regulated under stress conditions, including oxidative stress and starvation, resulting in a significant increase in its content [192].
The m5C modification is enriched at the 5′ UTR and near the CDS start [195,196]. While m5C has been demonstrated to suppress translation, the observed effects are more likely to be associated with sites located in the CDS rather than in the 5′ UTR [195,196].
The conversion of adenosine to inosine is a rare occurrence in 5′ UTRs, being more prevalent in 3′ UTRs [197]. However, it is noteworthy that the replacement of adenosine by inosine results in the activation of “latent” rG4 [198]. rG4 are observed in both 3′ and 5′ UTRs, thereby highlighting the potential significance of inosine in the regulation of 5′ UTRs.
The presence of the ac4C modification in human mRNA is currently a matter of debate in the scientific community. In 2018, a group of researchers published data suggesting that ac4C is distributed throughout human mRNA, with an enrichment observed in the 5′ UTR near the translation initiation site [199]. Subsequent studies by the same authors revealed that the impact of ac4C on translation depends on the context, promoting translation initiation at non-canonical start codons (CUG) in 5′ UTRs and inhibiting translation in Kozak (AUG) contexts [200]. However, an opposing study in 2020 claims that ac4C is not present at all in human and yeast mRNA [201]. This discrepancy underscores a need for further investigation into the role of ac4C modification in eukaryotic RNA.
The current state of knowledge regarding the effects of different nucleotide modifications in 5′ UTRs on translation is limited due to a number of instrumental problems [202]. Firstly, the mapping of different modifications across the entire transcriptome is challenging for a number of reasons, including methodological artifacts and annotation errors. Secondly, even reliable data does not provide a comprehensive understanding of dynamic regulation. The current approaches utilize methyltransferase knockouts, which only allow changes in modification status to be seen across the entire transcriptome. Additionally, the study of site-specific regulation is hindered by the fact that the same enzyme typically introduces modifications at different positions and a change in its expression can lead to a global rearrangement of processes in the cell. However, the enrichment of modifications near functionally important 5′ UTR regions, such as the translation initiation site, indicates that they may play an important role in the regulation of gene expression and this aspect requires further study.

6. Trans-Acting Factors

As discussed in previous sections, 5′ UTR-mediated translation regulation by trans-acting factors involves various elements, such as the coupling of LARP1 and TOP, ITAFs, and IRES. In addition to these examples, it is important to consider cases where the interaction is sequence-determined. This includes a variety of RBPs that recognize specific sequences within the 5′ UTR, as well as complementary long non-coding RNAs (lncRNAs) and microRNAs (miRNAs).
For example, HuD, an RNA-binding protein, has been shown to be associated with a 22-nucleotide segment of the 5′ UTR of preproinsulin [203]. The overexpression of HuD suppresses the translation of the insulin precursor, while glucose treatment causes the dissociation of HuD from Ins2 mRNA and increases insulin production, respectively. It has been hypothesized that microRNA-196b can enhance insulin translation by binding to the 5′ UTR and displacing the HuD inhibitor [204]. Additionally, studies have demonstrated that the splicing factor SRSF3 not only regulates splicing but also suppresses the translation of its target PDCD4 by directly binding to the 5′ UTR [205]. The list of RNPs regulating translation continues to grow, and in silico evidence suggests that there is a wide range of multifunctional RBPs that bind 5′ UTRs [206,207]. However, it should be noted that such proteins often bind both ends of the UTR, and it is not yet known which interaction determines the regulation.
The most studied trans-acting long non-coding RNA (lncRNA) is the antisense RNA that controls the translation of Uchl1 [208]. This RNA has a complementary region to Uchl1 mRNA and an “effector domain” that enhances translation. The non-complementary sequence of the RNA contains SINEs (short interspersed repetitive elements), specifically SINEB2 of subclass B3. This work initiated the study of a class of long non-coding RNAs (lncRNAs) called SINEUP: lncRNA translation enhancers containing SINEs. A number of other examples of antisense RNAs that regulate translation in this manner were later found, e.g., R12A-AS1 [209], Uxt [208], and AS-RBM15 [210]. However, the precise mechanism by which antisense RNAs enhance translation remains to be elucidated. SINEUPs have been observed to colocalize with their mRNA, facilitated by RNA-binding proteins PTBP1 and HNRNPK [211]. Additionally, studies have shown that m6A modification is necessary for optimal SINEUP function [212]. A recent study reported that SINEs can bind ribosomal RNA [213], and a recently published preprint suggests that the effector domain functions as an IRES [214]. Given the versatility of long non-coding RNA (lncRNA) with an antisense and effector domain structure, the potential of SINEUP in therapeutic applications to enhance gene expression is a promising avenue for further exploration [215,216,217].

7. Conclusions

The efficiency of translation is determined by a set of mRNA structural elements located in 5′ UTRs, which exert different, often opposite effects on the process of protein synthesis. These elements interact in a complex manner, allowing the cell to dynamically and precisely regulate translation in response to environmental changes, ensuring a high degree of adaptability. The accumulated data emphasize the need for a systems approach, including the integration of omics studies, to unravel the molecular mechanisms of translation regulation of individual genes. This comprehensive approach will facilitate a more profound understanding of how the structural characteristics of mRNAs influence the expression programs of diverse genes.
Beyond its fundamental importance, the study of the regulatory mechanisms of translation offers considerable potential for practical applications. This knowledge can be used to create new tools in synthetic biology, develop targeted therapy, and improve mRNA vaccine technology. The controlled translation of target mRNAs, predicated on an understanding of their structural features, promises to substantially expand the scope of their applications in biomedicine and biotechnology.

Author Contributions

Conceptualization, M.R., E.R. and N.S.; writing—original draft preparation, E.R. and A.M.; writing—review and editing, N.S., M.R. and O.D.; project administration and funding acquisition, M.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Russian Scientific Foundation, grant number 23-14-00058.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
UTRuntranslated region
IRESinternal ribosome entry site
TOPterminal oligopyrimidine tract
uORFupstream open reading frames
RANrepeat-associated non-AUG (translation)
TISUtranslation initiators of short 5′ UTRs
PRTEpyrimidine-rich translation elements
rG4RNA G-quadruplexes
CDSCoding sequences
CITEcap-independent translation enhancer
ITAFIRES trans-acting factors

References

  1. Zhang, L.; Kasif, S.; Cantor, C.R.; Broude, N.E. GC/AT-Content Spikes as Genomic Punctuation Marks. Proc. Natl. Acad. Sci. USA 2004, 101, 16855–16860. [Google Scholar] [CrossRef] [PubMed]
  2. Leppek, K.; Das, R.; Barna, M. Functional 5′ UTR mRNA Structures in Eukaryotic Translation Regulation and How to Find Them. Nat. Rev. Mol. Cell Biol. 2018, 19, 158–174. [Google Scholar] [CrossRef]
  3. Wieder, N.; D’Souza, E.N.; Martin-Geary, A.C.; Lassen, F.H.; Talbot-Martin, J.; Fernandes, M.; Chothani, S.P.; Rackham, O.J.L.; Schafer, S.; Aspden, J.L.; et al. Differences in 5′untranslated Regions Highlight the Importance of Translational Regulation of Dosage Sensitive Genes. Genome Biol. 2024, 25, 111. [Google Scholar] [CrossRef] [PubMed]
  4. Haimov, O.; Sinvani, H.; Dikstein, R. Cap-Dependent, Scanning-Free Translation Initiation Mechanisms. Biochim. Biophys. Acta 2015, 1849, 1313–1318. [Google Scholar] [CrossRef] [PubMed]
  5. Montoya, J.; Ojala, D.; Attardi, G. Distinctive Features of the 5′-Terminal Sequences of the Human Mitochondrial mRNAs. Nature 1981, 290, 465–470. [Google Scholar] [CrossRef] [PubMed]
  6. Sonneveld, S.; Bram, M.P.V.; Marvin, E. Tanenbaum Heterogeneity in mRNA Translation. Trends Cell Biol. 2020, 30, 606–618. [Google Scholar] [CrossRef]
  7. Aitken, C.E.; Lorsch, J.R. A Mechanistic Overview of Translation Initiation in Eukaryotes. Nat. Struct. Mol. Biol. 2012, 19, 568–576. [Google Scholar] [CrossRef]
  8. Parra, C.; Ernlund, A.; Alard, A.; Ruggles, K.; Ueberheide, B.; Schneider, R.J. A Widespread Alternate Form of Cap-Dependent mRNA Translation Initiation. Nat. Commun. 2018, 9, 3068. [Google Scholar] [CrossRef] [PubMed]
  9. Green, K.M.; Linsalata, A.E.; Todd, P.K. RAN Translation—What Makes It Run? Brain Res. 2016, 1647, 30–42. [Google Scholar] [CrossRef] [PubMed]
  10. Tseng, Y.-J.; Krans, A.; Malik, I.; Deng, X.; Yildirim, E.; Ovunc, S.; Tank, E.M.H.; Jansen-West, K.; Kaufhold, R.; Gomez, N.B.; et al. Ribosomal Quality Control Factors Inhibit Repeat-Associated Non-AUG Translation from GC-Rich Repeats. Nucleic Acids Res. 2024, 52, 5928–5949. [Google Scholar] [CrossRef] [PubMed]
  11. Cleary, J.D.; Pattamatta, A.; Ranum, L.P.W. Repeat-Associated Non-ATG (RAN) Translation. J. Biol. Chem. 2018, 293, 16127–16141. [Google Scholar] [CrossRef] [PubMed]
  12. Meyuhas, O.; Kahan, T. The Race to Decipher the Top Secrets of TOP mRNAs. Biochim. Biophys. Acta 2015, 1849, 801–811. [Google Scholar] [CrossRef] [PubMed]
  13. Lucas, P.; van den Elzen, A.; Watson, M.J.; Carson, T. Global Analysis of LARP1 Translation Targets Reveals Tunable and Dynamic Features of 5′ TOP Motifs. Proc. Natl. Acad. Sci. USA 2020, 117, 5319–5328. [Google Scholar] [CrossRef]
  14. Jensen, K.B.; Dredge, B.K.; Toubia, J.; Jin, X.; Iadevaia, V.; Goodall, G.J.; Proud, C.G. capCLIP: A New Tool to Probe Translational Control in Human Cells through Capture and Identification of the eIF4E–mRNA Interactome. Nucleic Acids Res. 2021, 49, e105. [Google Scholar] [CrossRef] [PubMed]
  15. Gan, S.; Su, C.; Ma, J.; Liu, M.; Cui, X.; Xin, L.; Ren, Y.; Gao, X.; Ge, L.; Wei, M.; et al. Translation of Tudor-SN, a Novel Terminal Oligo-Pyrimidine (TOP) mRNA, Is Regulated by the mTORC1 Pathway in Cardiomyocytes. RNA Biol. 2021, 18, 900–913. [Google Scholar] [CrossRef]
  16. Setayesh, T.; Colquhoun, S.D.; Wan, Y.-J.Y. Overexpression of Galectin-1 and Galectin-3 in Hepatocellular Carcinoma. Liver Res. 2020, 4, 173–179. [Google Scholar] [CrossRef] [PubMed]
  17. Liu, A.-B.; Liu, J.; Wang, S.; Ma, L.; Zhang, J.-F. Biological Role and Expression of Translationally Controlled Tumor Protein (TCTP) in Tumorigenesis and Development and Its Potential for Targeted Tumor Therapy. Cancer Cell Int. 2024, 24, 198. [Google Scholar] [CrossRef] [PubMed]
  18. Chen, Z.; Xie, Y.; Luo, H.; Song, Y.; Que, T.; Hu, R.; Huang, H.; Luo, K.; Li, C.; Qin, C.; et al. NAP1L1 Promotes Proliferation and Chemoresistance in Glioma by Inducing CCND1/CDK4/CDK6 Expression through Its Interaction with HDGF and Activation of c-Jun. Aging 2021, 13, 26180–26200. [Google Scholar] [CrossRef] [PubMed]
  19. Ryu, H.G.; Jung, Y.; Lee, N.; Seo, J.-Y.; Kim, S.W.; Lee, K.-H.; Kim, D.-Y.; Kim, K.-T. HNRNP A1 Promotes Lung Cancer Cell Proliferation by Modulating VRK1 Translation. Int. J. Mol. Sci. 2021, 22, 5506. [Google Scholar] [CrossRef] [PubMed]
  20. Usman, S.; Waseem, N.H.; Nguyen, T.K.N.; Mohsin, S.; Jamal, A.; Teh, M.-T.; Waseem, A. Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers 2021, 13, 4985. [Google Scholar] [CrossRef] [PubMed]
  21. Dermani, F.K.; Khoei, S.G.; Afshar, S.; Amini, R. The potential role of nucleophosmin (NPM1) in the development of cancer. J. Cell. Physiol. 2021, 236, 7832–7852. [Google Scholar] [CrossRef]
  22. Yoshino, Y.; Chiba, N. Roles of RACK1 in Centrosome Regulation and Carcinogenesis. Cell Signal 2022, 90, 110207. [Google Scholar] [CrossRef]
  23. Hsieh, A.C.; Liu, Y.; Edlind, M.P.; Ingolia, N.T.; Janes, M.R.; Sher, A.; Shi, E.Y.; Stumpf, C.R.; Christensen, C.; Bonham, M.J.; et al. The Translational Landscape of mTOR Signalling Steers Cancer Initiation and Metastasis. Nature 2012, 485, 55–61. [Google Scholar] [CrossRef]
  24. Yamashita, R.; Suzuki, Y.; Takeuchi, N.; Wakaguri, H.; Ueda, T.; Sugano, S.; Nakai, K. Comprehensive Detection of Human Terminal Oligo-Pyrimidine (TOP) Genes and Analysis of Their Characteristics. Nucleic Acids Res. 2008, 36, 3707–3715. [Google Scholar] [CrossRef] [PubMed]
  25. Hochstoeger, T.; Chao, J.A. Towards a Molecular Understanding of the 5′TOP Motif in Regulating Translation of Ribosomal mRNAs. Semin. Cell Dev. Biol. 2024, 154, 99–104. [Google Scholar] [CrossRef] [PubMed]
  26. Weber, R.; Ghoshdastider, U.; Spies, D.; Duré, C.; Valdivia-Francia, F.; Forny, M.; Ormiston, M.; Renz, P.F.; Taborsky, D.; Yigit, M.; et al. Monitoring the 5′UTR Landscape Reveals Isoform Switches to Drive Translational Efficiencies in Cancer. Oncogene 2023, 42, 638–650. [Google Scholar] [CrossRef]
  27. Farooq, Z.; Kusuma, F.; Burke, P.; Dufour, C.R.; Lee, D.; Tabatabaei, N.; Toboz, P.; Radovani, E.; Greenblatt, J.F.; Rehman, J.; et al. The Amino Acid Sensor GCN2 Suppresses Terminal Oligopyrimidine (TOP) mRNA Translation via La-Related Protein 1 (LARP1). J. Biol. Chem. 2022, 298, 102277. [Google Scholar] [CrossRef] [PubMed]
  28. Gismondi, A.; Caldarola, S.; Lisi, G.; Juli, G.; Chellini, L.; Iadevaia, V.; Proud, C.G.; Loreni, F. Ribosomal Stress Activates eEF2K–eEF2 Pathway Causing Translation Elongation Inhibition and Recruitment of Terminal Oligopyrimidine (TOP) mRNAs on Polysomes. Nucleic Acids Res. 2014, 42, 12668–12680. [Google Scholar] [CrossRef] [PubMed]
  29. Li, B.B.; Qian, C.; Gameiro, P.A.; Liu, C.-C.; Jiang, T.; Roberts, T.M.; Struhl, K.; Zhao, J.J. Targeted Profiling of RNA Translation Reveals mTOR-4EBP1/2-Independent Translation Regulation of mRNAs Encoding Ribosomal Proteins. Proc. Natl. Acad. Sci. USA 2018, 115, E9325–E9332. [Google Scholar] [CrossRef] [PubMed]
  30. Cockman, E.; Anderson, P.; Ivanov, P. TOP mRNPs: Molecular Mechanisms and Principles of Regulation. Biomolecules 2020, 10, 969. [Google Scholar] [CrossRef] [PubMed]
  31. del Valle Morales, D.; Trotman, J.B.; Bundschuh, R.; Schoenberg, D.R. Inhibition of Cytoplasmic Cap Methylation Identifies 5′ TOP mRNAs as Recapping Targets and Reveals Recapping Sites Downstream of Native 5′ Ends. Nucleic Acids Res. 2020, 48, 3806–3815. [Google Scholar] [CrossRef]
  32. Jia, J.-J.; Lahr, R.M.; Solgaard, M.T.; Moraes, B.J.; Pointet, R.; Yang, A.-D.; Celucci, G.; Graber, T.E.; Hoang, H.-D.; Niklaus, M.R.; et al. mTORC1 Promotes TOP mRNA Translation through Site-Specific Phosphorylation of LARP1. Nucleic Acids Res. 2021, 49, 3461–3489. [Google Scholar] [CrossRef]
  33. Shichino, Y.; Yamaguchi, T.; Kashiwagi, K.; Mito, M.; Takahashi, M.; Ito, T.; Ingolia, N.T.; Kuba, K.; Iwasaki, S. eIF4A1 Enhances LARP1-Mediated Translational Repression during mTORC1 Inhibition. Nat. Struct. Mol. Biol. 2024, 31, 1557–1566. [Google Scholar] [CrossRef]
  34. Park, J.; Kim, M.; Yi, H.; Baeg, K.; Choi, Y.; Lee, Y.; Lim, J.; Kim, V.N. Short Poly(A) Tails Are Protected from Deadenylation by the LARP1–PABP Complex. Nat. Struct. Mol. Biol. 2023, 30, 330–338. [Google Scholar] [CrossRef] [PubMed]
  35. Ogami, K.; Oishi, Y.; Sakamoto, K.; Okumura, M.; Yamagishi, R.; Inoue, T.; Hibino, M.; Nogimori, T.; Yamaguchi, N.; Furutachi, K.; et al. mTOR- and LARP1-Dependent Regulation of TOP mRNA Poly(A) Tail and Ribosome Loading. Cell Rep. 2022, 41, 111548. [Google Scholar] [CrossRef] [PubMed]
  36. Mattijssen, S.; Kozlov, G.; Gaidamakov, S.; Ranjan, A.; Fonseca, B.D.; Gehring, K.; Maraia, R.J. The Isolated La-Module of LARP1 Mediates 3′ Poly(A) Protection and mRNA Stabilization, Dependent on Its Intrinsic PAM2 Binding to PABPC1. RNA Biol. 2021, 18, 275–289. [Google Scholar] [CrossRef] [PubMed]
  37. Hochstoeger, T.; Papasaikas, P.; Piskadlo, E.; Chao, J.A. Distinct Roles of LARP1 and 4EBP1/2 in Regulating Translation and Stability of 5′TOP mRNAs. Sci. Adv. 2024, 10, eadi7830. [Google Scholar] [CrossRef] [PubMed]
  38. Fuentes, P.; Pelletier, J.; Martinez-Herráez, C.; Diez-Obrero, V.; Iannizzotto, F.; Rubio, T.; Garcia-Cajide, M.; Menoyo, S.; Moreno, V.; Salazar, R.; et al. The 40S-LARP1 Complex Reprograms the Cellular Translatome upon mTOR Inhibition to Preserve the Protein Synthetic Capacity. Sci. Adv. 2021, 7, eabg9275. [Google Scholar] [CrossRef] [PubMed]
  39. Gentilella, A.; Morón-Duran, F.D.; Fuentes, P.; Zweig-Rocha, G.; Riaño-Canalias, F.; Pelletier, J.; Ruiz, M.; Turón, G.; Castaño, J.; Tauler, A.; et al. Autogenous Control of 5′TOP mRNA Stability by 40S Ribosomes. Mol. Cell 2017, 67, 55–70.e4. [Google Scholar] [CrossRef] [PubMed]
  40. Saba, J.A.; Huang, Z.; Schole, K.L.; Ye, X.; Bhatt, S.D.; Li, Y.; Timp, W.; Cheng, J.; Green, R. LARP1 Senses Free Ribosomes to Coordinate Supply and Demand of Ribosomal Proteins. bioRxiv 2023. [Google Scholar]
  41. Mansouri-Noori, F.; Pircher, A.; Bilodeau, D.; Siniavskaia, L.; Grigull, J.; Rissland, O.S.; Bayfield, M.A. The LARP1 Homolog Slr1p Controls the Stability and Expression of Proto-5′TOP mRNAs in Fission Yeast. Cell Rep. 2023, 42, 113226. [Google Scholar] [CrossRef]
  42. Kozak, M. At Least Six Nucleotides Preceding the AUG Initiator Codon Enhance Translation in Mammalian Cells. J. Mol. Biol. 1987, 196, 947–950. [Google Scholar] [CrossRef] [PubMed]
  43. Loughran, G.; Sachs, M.S.; Atkins, J.F.; Ivanov, I.P. Stringency of Start Codon Selection Modulates Autoregulation of Translation Initiation Factor eIF5. Nucleic Acids Res. 2012, 40, 2898–2906. [Google Scholar] [CrossRef] [PubMed]
  44. Ivanov, I.P.; Firth, A.E.; Michel, A.M.; Atkins, J.F.; Baranov, P.V. Identification of Evolutionarily Conserved Non-AUG-Initiated N-Terminal Extensions in Human Coding Sequences. Nucleic Acids Res. 2011, 39, 4220–4234. [Google Scholar] [CrossRef] [PubMed]
  45. Kostenis, E.; Degtyarev, M.Y.; Conklin, B.R.; Wess, J. The N-Terminal Extension of Gαq Is Critical for Constraining the Selectivity of Receptor Coupling. J. Biol. Chem. 1997, 272, 19107–19110. [Google Scholar] [CrossRef]
  46. Sunn, K.L.; Cock, T.-A.; Crofts, L.A.; Eisman, J.A.; Gardiner, E.M. Novel N-Terminal Variant of Human VDR. Mol. Endocrinol. 2001, 15, 1599–1609. [Google Scholar] [CrossRef] [PubMed]
  47. Wang, Y.; Zhang, H.; Lu, J. Recent Advances in Ribosome Profiling for Deciphering Translational Regulation. Methods 2020, 176, 46–54. [Google Scholar] [CrossRef] [PubMed]
  48. Valdivia-Francia, F.; Sendoel, A. No Country for Old Methods: New Tools for Studying Microproteins. iScience 2024, 27, 108972. [Google Scholar] [CrossRef]
  49. Yang, H.; Li, Q.; Stroup, E.K.; Wang, S.; Ji, Z. Widespread Stable Noncanonical Peptides Identified by Integrated Analyses of Ribosome Profiling and ORF Features. Nat. Commun. 2024, 15, 1932. [Google Scholar] [CrossRef]
  50. Mudge, J.M.; Ruiz-Orera, J.; Prensner, J.R.; Brunet, M.A.; Calvet, F.; Jungreis, I.; Gonzalez, J.M.; Magrane, M.; Martinez, T.F.; Schulz, J.F.; et al. Standardized Annotation of Translated Open Reading Frames. Nat. Biotechnol. 2022, 40, 994–999. [Google Scholar] [CrossRef] [PubMed]
  51. Chothani, S.P.; Adami, E.; Widjaja, A.A.; Langley, S.R.; Viswanathan, S.; Pua, C.J.; Zhihao, N.T.; Harmston, N.; D’Agostino, G.; Whiffin, N.; et al. A High-Resolution Map of Human RNA Translation. Mol. Cell 2022, 82, 2885–2899.e8. [Google Scholar] [CrossRef]
  52. Sandmann, C.-L.; Schulz, J.F.; Ruiz-Orera, J.; Kirchner, M.; Ziehm, M.; Adami, E.; Marczenke, M.; Christ, A.; Liebe, N.; Greiner, J.; et al. Evolutionary Origins and Interactomes of Human, Young Microproteins and Small Peptides Translated from Short Open Reading Frames. Mol. Cell 2023, 83, 994–1011.e18. [Google Scholar] [CrossRef]
  53. Dasgupta, A.; Prensner, J.R. Upstream Open Reading Frames: New Players in the Landscape of Cancer Gene Regulation. NAR Cancer 2024, 6, zcae023. [Google Scholar] [CrossRef] [PubMed]
  54. Young, S.K.; Wek, R.C. Upstream Open Reading Frames Differentially Regulate Gene-Specific Translation in the Integrated Stress Response. J. Biol. Chem. 2016, 291, 16927–16935. [Google Scholar] [CrossRef] [PubMed]
  55. Thiadens, K.A.M.H.; Klerck, E.; Fokkema, I.F.A.C.; Hoen, P.A.C.; von Lindern, M. Ribosome Profiling Uncovers the Role of uORFs in Translational Control of Gene Expression during Erythroblast Differentiation. Blood 2014, 124, 2658. [Google Scholar] [CrossRef]
  56. Barbosa, C.; Peixeiro, I.; Romão, L. Gene Expression Regulation by Upstream Open Reading Frames and Human Disease. PLoS Genet. 2013, 9, e1003529. [Google Scholar] [CrossRef] [PubMed]
  57. Dever, T.E.; Ivanov, I.P.; Hinnebusch, A.G. Translational Regulation by uORFs and Start Codon Selection Stringency. Genes Dev. 2023, 37, 474–489. [Google Scholar] [CrossRef]
  58. Kozak, M. Constraints on Reinitiation of Translation in Mammals. Nucleic Acids Res. 2001, 29, 5226–5232. [Google Scholar] [CrossRef] [PubMed]
  59. Liu, B.; Qian, S.-B. Translational Reprogramming in Cellular Stress Response. WIREs RNA 2014, 5, 301–305. [Google Scholar] [CrossRef]
  60. Palam, L.R.; Baird, T.D.; Wek, R.C. Phosphorylation of eIF2 Facilitates Ribosomal Bypass of an Inhibitory Upstream ORF to Enhance CHOP Translation. J. Biol. Chem. 2011, 286, 10939–10949. [Google Scholar] [CrossRef]
  61. Adomavicius, T.; Guaita, M.; Zhou, Y. The Structural Basis of Translational Control by eIF2 Phosphorylation. Nat. Commun. 2019, 10, 2136. [Google Scholar] [CrossRef] [PubMed]
  62. Krishna, M.V.; Ronald, C. Wek Reinitiation Involving Upstream ORFs Regulates ATF4 mRNA Translation in Mammalian Cells. Proc. Natl. Acad. Sci. USA 2004, 101, 11269–11274. [Google Scholar] [CrossRef]
  63. Smirnova, A.M.; Hronová, V.; Mohammad, M.P.; Herrmannová, A.; Gunišová, S.; Petráčková, D.; Halada, P.; Coufal, Š.; Świrski, M.; Rendleman, J.; et al. Stem-Loop-Induced Ribosome Queuing in the uORF2/ATF4 Overlap Fine-Tunes Stress-Induced Human ATF4 Translational Control. Cell Rep. 2024, 43, 113976. [Google Scholar] [CrossRef] [PubMed]
  64. Amin, P.H.; Carlson, K.R.; Wek, R.C. An RNA Stem-Loop Functions in Conjunction with an Upstream Open Reading Frame to Direct Preferential Translation in the Integrated Stress Response. J. Biol. Chem. 2023, 299, 102864. [Google Scholar] [CrossRef]
  65. Murat, P.; Marsico, G.; Herdy, B.; Ghanbarian, A.; Portella, G.; Balasubramanian, S. RNA G-Quadruplexes at Upstream Open Reading Frames Cause DHX36- and DHX9-Dependent Translation of Human mRNAs. Genome Biol. 2018, 19, 229. [Google Scholar] [CrossRef] [PubMed]
  66. Kozak, M. Downstream Secondary Structure Facilitates Recognition of Initiator Codons by Eukaryotic Ribosomes. Proc. Natl. Acad. Sci. USA 1990, 87, 8301–8305. [Google Scholar] [CrossRef] [PubMed]
  67. Fernandez, J.; Yaman, I.; Huang, C.; Liu, H.; Lopez, A.B.; Komar, A.A.; Caprara, M.G.; Merrick, W.C.; Snider, M.D.; Kaufman, R.J.; et al. Ribosome Stalling Regulates IRES-Mediated Translation in Eukaryotes, a Parallel to Prokaryotic Attenuation. Mol. Cell 2005, 17, 405–416. [Google Scholar] [CrossRef]
  68. Meijer, H.A.; Thomas, A.A.M. Ribosomes Stalling on uORF1 in the Xenopus Cx41 5′ UTR Inhibit Downstream Translation Initiation. Nucleic Acids Res. 2003, 31, 3174–3184. [Google Scholar] [CrossRef] [PubMed]
  69. Lin, Y.; May, G.E.; Kready, H.; Nazzaro, L.; Mao, M.; Spealman, P.; Creeger, Y.; McManus, C.J. Impacts of uORF Codon Identity and Position on Translation Regulation. Nucleic Acids Res. 2019, 47, 9358–9367. [Google Scholar] [CrossRef]
  70. Park, M.H.; Wolff, E.C. Hypusine, a Polyamine-Derived Amino Acid Critical for Eukaryotic Translation. J. Biol. Chem. 2018, 293, 18710–18718. [Google Scholar] [CrossRef]
  71. Venkataramanan, S.; Floor, S.N. The Traffic Jam: Polyamine Prevalence Pauses Protein Production. Mol. Cell 2018, 70, 191–192. [Google Scholar] [CrossRef] [PubMed]
  72. Ivanov, I.P.; Shin, B.-S.; Loughran, G.; Tzani, I.; Young-Baird, S.K.; Cao, C.; Atkins, J.F.; Dever, T.E. Polyamine Control of Translation Elongation Regulates Start Site Selection on Antizyme Inhibitor mRNA via Ribosome Queuing. Mol. Cell 2018, 70, 254–264.e6. [Google Scholar] [CrossRef] [PubMed]
  73. Pegg, A.E. Functions of Polyamines in Mammals. J. Biol. Chem. 2016, 291, 14904–14912. [Google Scholar] [CrossRef] [PubMed]
  74. Raney, A.; Baron, A.C.; Mize, G.J.; Law, G.L.; Morris, D.R. In Vitro Translation of the Upstream Open Reading Frame in the Mammalian mRNA Encoding S-Adenosylmethionine Decarboxylase. J. Biol. Chem. 2000, 275, 24444–24450. [Google Scholar] [CrossRef] [PubMed]
  75. Hill, J.R.; Morris, D.R. Cell-Specific Translational Regulation of S-Adenosylmethionine Decarboxylase mRNA. Dependence on Translation and Coding Capacity of the Cis-Acting Upstream Open Reading Frame. J. Biol. Chem. 1993, 268, 726–731. [Google Scholar] [CrossRef] [PubMed]
  76. Law, G.L.; Raney, A.; Heusner, C.; Morris, D.R. Polyamine Regulation of Ribosome Pausing at the Upstream Open Reading Frame of S-Adenosylmethionine Decarboxylase. J. Biol. Chem. 2001, 276, 38036–38043. [Google Scholar] [CrossRef] [PubMed]
  77. Ivanov, I.P.; Atkins, J.F.; Michael, A.J. A Profusion of Upstream Open Reading Frame Mechanisms in Polyamine-Responsive Translational Regulation. Nucleic Acids Res. 2009, 38, 353–359. [Google Scholar] [CrossRef] [PubMed]
  78. Werner, M.; Feller, A.; Messenguy, F.; Piérard, A. The Leader Peptide of Yeast Gene CPA1 Is Essential for the Translational Repression of Its Expression. Cell 1987, 49, 805–813. [Google Scholar] [CrossRef]
  79. Wu, C.; Wei, J.; Lin, P.-J.; Tu, L.; Deutsch, C.; Johnson, A.E.; Sachs, M.S. Arginine Changes the Conformation of the Arginine Attenuator Peptide Relative to the Ribosome Tunnel. J. Mol. Biol. 2012, 416, 518–533. [Google Scholar] [CrossRef] [PubMed]
  80. Gaba, A.; Jacobson, A.; Sachs, M.S. Ribosome Occupancy of the Yeast CPA1 Upstream Open Reading Frame Termination Codon Modulates Nonsense-Mediated mRNA Decay. Mol. Cell 2005, 20, 449–460. [Google Scholar] [CrossRef]
  81. He, F.; Li, X.; Spatrick, P.; Casillo, R.; Dong, S.; Jacobson, A. Genome-Wide Analysis of mRNAs Regulated by the Nonsense-Mediated and 5′ to 3′ mRNA Decay Pathways in Yeast. Mol. Cell 2003, 12, 1439–1452. [Google Scholar] [CrossRef] [PubMed]
  82. Nyikó, T.; Sonkoly, B.; Mérai, Z.; Benkovics, A.H.; Silhavy, D. Plant Upstream ORFs Can Trigger Nonsense-Mediated mRNA Decay in a Size-Dependent Manner. Plant Mol. Biol. 2009, 71, 367. [Google Scholar] [CrossRef] [PubMed]
  83. van der Horst, S.; Filipovska, T.; Hanson, J.; Smeekens, S. Metabolite Control of Translation by Conserved Peptide uORFs: The Ribosome as a Metabolite Multisensor. Plant Physiol. 2020, 182, 110–122. [Google Scholar] [CrossRef]
  84. Jayaram, D.R.; Frost, S.; Argov, C.; Livneh, E. Unraveling the Hidden Role of a uORF-Encoded Peptide as a Kinase Inhibitor of PKCs. Proc. Natl. Acad. Sci. USA 2021, 118, e2018899118. [Google Scholar] [CrossRef]
  85. Cloutier, P.; Poitras, C.; Faubert, D.; Bouchard, A.; Blanchette, M.; Gauthier, M.-S.; Coulombe, B. Upstream ORF-Encoded ASDURF Is a Novel Prefoldin-like Subunit of the PAQosome. J. Proteome Res. 2020, 19, 18–27. [Google Scholar] [CrossRef] [PubMed]
  86. Hofman, D.A.; Ruiz-Orera, J.; Yannuzzi, I.; Murugesan, R.; Brown, A.; Clauser, K.R.; Condurat, A.L.; van Dinter, J.T.; Engels, S.A.G.; Goodale, A.; et al. Translation of Non-Canonical Open Reading Frames as a Cancer Cell Survival Mechanism in Childhood Medulloblastoma. Mol. Cell 2024, 84, 261–276.e18. [Google Scholar] [CrossRef]
  87. Mou, R.; Niu, R.; Yang, R.; Xu, G. Engineering Crop Performance with Upstream Open Reading Frames. Trends Plant Sci. 2024, 24, 1360–1385. [Google Scholar] [CrossRef]
  88. Um, T.; Park, T.; Shim, J.S.; Kim, Y.S.; Lee, G.-S.; Choi, I.-Y.; Kim, J.-K.; Seo, J.S.; Park, S.C. Application of Upstream Open Reading Frames (uORFs) Editing for the Development of Stress-Tolerant Crops. Int. J. Mol. Sci. 2021, 22, 3743. [Google Scholar] [CrossRef] [PubMed]
  89. Fernandez, J.; Yaman, I.; Merrick, W.C.; Koromilas, A.; Wek, R.C.; Sood, R.; Hensold, J.; Hatzoglou, M. Regulation of Internal Ribosome Entry Site-Mediated Translation by Eukaryotic Initiation Factor-2α Phosphorylation and Translation of a Small Upstream Open Reading Frame. J. Biol. Chem. 2002, 277, 2050–2058. [Google Scholar] [CrossRef] [PubMed]
  90. Nijs, Y.D.; Maeseneire, S.L.D.; Soetaert, W.K. 5′ untranslated regions: The next regulatory sequence in yeast synthetic biology. Biol. Rev. 2019, 95, 517–529. [Google Scholar] [CrossRef]
  91. Silva, J.; Fernandes, R.; Romão, L. Translational Regulation by Upstream Open Reading Frames and Human Diseases. In The mRNA Metabolism in Human Disease; Romão, L., Ed.; Springer International Publishing: Cham, Switzerland, 2019; pp. 99–116. ISBN 978-3-030-19966-1. [Google Scholar]
  92. Muckenthaler, M.; Gray, N.K.; Hentze, M.W. IRP-1 Binding to Ferritin mRNA Prevents the Recruitment of the Small Ribosomal Subunit by the Cap-Binding Complex eIF4F. Mol. Cell 1998, 2, 383–388. [Google Scholar] [CrossRef]
  93. Hentze, M.W.; Caughman, S.W.; Rouault, T.A.; Barriocanal, J.G.; Dancis, A.; Harford, J.B.; Klausner, R.D. Identification of the Iron-Responsive Element for the Translational Regulation of Human Ferritin mRNA. Science 1987, 238, 1570–1573. [Google Scholar] [CrossRef] [PubMed]
  94. Walker, M.J.; Shortridge, M.D.; Albin, D.D.; Cominsky, L.Y.; Varani, G. Structure of the RNA Specialized Translation Initiation Element That Recruits eIF3 to the 5′-UTR of c-Jun. J. Mol. Biol. 2020, 432, 1841–1855. [Google Scholar] [CrossRef] [PubMed]
  95. Lee, A.S.Y.; Kranzusch, P.J.; Cate, J.H.D. eIF3 Targets Cell-Proliferation Messenger RNAs for Translational Activation or Repression. Nature 2015, 522, 111–114. [Google Scholar] [CrossRef]
  96. Grayeski, P.J.; Weidmann, C.A.; Kumar, J.; Lackey, L.; Mustoe, A.M.; Busan, S.; Laederach, A.; Weeks, K.M. Global 5′-UTR RNA Structure Regulates Translation of a SERPINA1 mRNA. Nucleic Acids Res. 2022, 50, 9689–9704. [Google Scholar] [CrossRef]
  97. Ben-Asouli, Y.; Banai, Y.; Pel-Or, Y.; Shir, A.; Kaempfer, R. Human Interferon-γ mRNA Autoregulates Its Translation through a Pseudoknot That Activates the Interferon-Inducible Protein Kinase PKR. Cell 2002, 108, 221–232. [Google Scholar] [CrossRef] [PubMed]
  98. Huang, X.; Du, Z. Possible involvement of three-stemmed pseudoknots in regulating translational initiation in human mRNAs. PLoS ONE 2024, 19, e0307541. [Google Scholar] [CrossRef]
  99. Kavita, K.; Breaker, R.R. Discovering Riboswitches: The Past and the Future. Trends Biochem. Sci. 2023, 48, 119–141. [Google Scholar] [CrossRef] [PubMed]
  100. Wachter, A. Riboswitch-Mediated Control of Gene Expression in Eukaryotes. RNA Biol. 2010, 7, 67–76. [Google Scholar] [CrossRef]
  101. Sun, W.; Zhang, X.; Chen, D.; Murchie, A.I.H. Interactions between the 5′ UTR mRNA of the Spe2 Gene and Spermidine Regulate Translation in S. Pombe. RNA 2020, 26, 137–149. [Google Scholar] [CrossRef] [PubMed]
  102. Zhang, X.; Sun, W.; Chen, D.; Murchie, A.I.H. Interactions between SAM and the 5′ UTR mRNA of the Sam1 Gene Regulate Translation in S. Pombe. RNA 2020, 26, 150–161. [Google Scholar] [CrossRef]
  103. Pavlova, N.; Kaloudas, D.; Penchovsky, R. Riboswitch Distribution, Structure, and Function in Bacteria. Gene 2019, 708, 38–48. [Google Scholar] [CrossRef] [PubMed]
  104. Giarimoglou, N.; Kouvela, A.; Maniatis, A.; Papakyriakou, A.; Zhang, J.; Stamatopoulou, V.; Stathopoulos, C. A Riboswitch-Driven Era of New Antibacterials. Antibiotics 2022, 11, 1243. [Google Scholar] [CrossRef]
  105. Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. [Google Scholar] [CrossRef] [PubMed]
  106. Nguyen, G.T.D.T.; Scaife, M.A.; Helliwell, K.E.; Smith, A.G. Role of riboswitches in gene regulation and their potential for algal biotechnology. J. Phycol. 2016, 52, 320–328. [Google Scholar] [CrossRef]
  107. Tabuchi, T.; Yokobayashi, Y. Cell-Free Riboswitches. RSC Chem. Biol. 2021, 2, 1430–1440. [Google Scholar] [CrossRef] [PubMed]
  108. Patel, S.; Panchasara, H.; Braddick, D.; Gohil, N.; Singh, V. Synthetic small RNAs: Current status, challenges, and opportunities. J. Cell Biochem. 2018, 119, 9619–9639. [Google Scholar] [CrossRef]
  109. Kim, J.; Cheong, C.; Moore, P.B. Tetramerization of an RNA Oligonucleotide Containing a GGGG Sequence. Nature 1991, 351, 331–332. [Google Scholar] [CrossRef] [PubMed]
  110. Kwok, C.K.; Marsico, G.; Sahakyan, A.B.; Chambers, V.S.; Balasubramanian, S. rG4-Seq Reveals Widespread Formation of G-Quadruplex Structures in the Human Transcriptome. Nat. Methods 2016, 13, 841–844. [Google Scholar] [CrossRef]
  111. Chow, E.Y.-C.; Lyu, K.; Kwok, C.K.; Chan, T.-F. rG4-Seeker Enables High-Confidence Identification of Novel and Non-Canonical rG4 Motifs from rG4-Seq Experiments. RNA Biol. 2020, 17, 903–917. [Google Scholar] [CrossRef] [PubMed]
  112. Yu, H.; Qi, Y.; Yang, B.; Yang, X.; Ding, Y. G4Atlas: A comprehensive transcriptome-wide G-quadruplex database. Nucleic Acids Res. 2022, 51, D126. [Google Scholar] [CrossRef]
  113. Fay, M.M.; Lyons, S.M.; Ivanov, P. RNA G-Quadruplexes in Biology: Principles and Molecular Mechanisms. J. Mol. Biol. 2017, 429, 2127–2147. [Google Scholar] [CrossRef] [PubMed]
  114. Lyu, K.; Chow, E.Y.-C.; Mou, X.; Chan, T.-F.; Kwok, C.K. RNA G-Quadruplexes (rG4s): Genomics and Biological Functions. Nucleic Acids Res. 2021, 49, 5426–5450. [Google Scholar] [CrossRef] [PubMed]
  115. Wang, Y.-H.; Yang, Q.-F.; Lin, X.; Chen, D.; Wang, Z.-Y.; Chen, B.; Han, H.-Y.; Chen, H.-D.; Cai, K.-C.; Li, Q.; et al. G4LDB 2.2: A Database for Discovering and Studying G-Quadruplex and i-Motif Ligands. Nucleic Acids Res. 2022, 50, D150–D160. [Google Scholar] [CrossRef] [PubMed]
  116. Bourdon, S.; Herviou, P.; Dumas, L.; Destefanis, E.; Zen, A.; Cammas, A.; Millevoi, S.; Dassi, E. QUADRatlas: The RNA G-Quadruplex and RG4-Binding Proteins Database. Nucleic Acids Res. 2023, 51, D240–D247. [Google Scholar] [CrossRef]
  117. Kharel, P.; Ivanov, P. Structure and Functions of RNA G-Quadruplexes. In RNA Structure and Function; Barciszewski, J., Ed.; Springer: Cham, Switzerland, 2023; Volume 14, pp. 183–203. [Google Scholar] [CrossRef]
  118. Guo, J.U.; Bartel, D.P. RNA G-Quadruplexes Are Globally Unfolded in Eukaryotic Cells and Depleted in Bacteria. Science 2016, 353, aaf5371. [Google Scholar] [CrossRef] [PubMed]
  119. Kharel, P.; Becker, G.; Tsvetkov, V.; Ivanov, P. Properties and Biological Impact of RNA G-Quadruplexes: From Order to Turmoil and Back. Nucleic Acids Res. 2020, 48, 12534–12555. [Google Scholar] [CrossRef]
  120. Biffi, G.; Di Antonio, M.; Tannahill, D.; Balasubramanian, S. Visualization and Selective Chemical Targeting of RNA G-Quadruplex Structures in the Cytoplasm of Human Cells. Nat. Chem. 2014, 6, 75–80. [Google Scholar] [CrossRef] [PubMed]
  121. Robinson, J.; Stenspil, S.G.; Maleckaite, K.; Bartlett, M.; Di Antonio, M.; Vilar, R.; Kuimova, M.K. Cellular Visualization of G-Quadruplex RNA via Fluorescence- Lifetime Imaging Microscopy. J. Am. Chem. Soc. 2024, 146, 1009–1018. [Google Scholar] [CrossRef]
  122. Zhang, S.; Sun, H.; Chen, H.; Li, Q.; Guan, A.; Wang, L.; Shi, Y.; Xu, S.; Liu, M.; Tang, Y. Direct Visualization of Nucleolar G-Quadruplexes in Live Cells by Using a Fluorescent Light-up Probe. Biochim. Biophys. Acta Gen. Subj. 2018, 1862, 1101–1106. [Google Scholar] [CrossRef] [PubMed]
  123. Lau, H.L.; Zhao, H.; Feng, H.; Kwok, C.K. Specific Targeting and Imaging of RNA G-Quadruplex (rG4) Structure Using Non-G4-Containing l-RNA Aptamer and Fluorogenic l-Aptamer. Small Methods 2024, e2401097. [Google Scholar] [CrossRef] [PubMed]
  124. Chen, S.-B.; Hu, M.-H.; Liu, G.-C.; Wang, J.; Ou, T.-M.; Gu, L.-Q.; Huang, Z.-S.; Tan, J.-H. Visualization of NRAS RNA G-Quadruplex Structures in Cells with an Engineered Fluorogenic Hybridization Probe. J. Am. Chem. Soc. 2016, 138, 10382–10385. [Google Scholar] [CrossRef] [PubMed]
  125. Chen, X.-C.; Chen, S.-B.; Dai, J.; Yuan, J.-H.; Ou, T.-M.; Huang, Z.-S.; Tan, J.-H. Tracking the Dynamic Folding and Unfolding of RNA G-Quadruplexes in Live Cells. Angew. Chem. Int. Ed. Engl. 2018, 57, 4702–4706. [Google Scholar] [CrossRef]
  126. Zheng, B.-X.; Long, W.; She, M.-T.; Wang, Y.; Zhao, D.; Yu, J.; Leung, A.S.-L.; Chan, K.H.; Hou, J.; Lu, Y.-J.; et al. A Cytoplasm-Specific Fluorescent Ligand for Selective Imaging of RNA G-Quadruplexes in Live Cancer Cells. Chemistry 2023, 29, e202300705. [Google Scholar] [CrossRef] [PubMed]
  127. Kitamura, A.; Tornmalm, J.; Demirbay, B.; Piguet, J.; Kinjo, M.; Widengren, J. Trans-Cis Isomerization Kinetics of Cyanine Dyes Reports on the Folding States of Exogeneous RNA G-Quadruplexes in Live Cells. Nucleic Acids Res. 2023, 51, e27. [Google Scholar] [CrossRef] [PubMed]
  128. Pandith, A.; Siddappa, R.G.; Seo, Y.J. Recent Developments in Novel Blue/Green/Red/NIR Small Fluorescent Probes for in Cellulo Tracking of RNA/DNA G-Quadruplexes. J. Photochem. Photobiol. C Photochem. Rev. 2019, 40, 81–116. [Google Scholar] [CrossRef]
  129. Bao, H.-L.; Ishizuka, T.; Sakamoto, T.; Fujimoto, K.; Uechi, T.; Kenmochi, N.; Xu, Y. Characterization of Human Telomere RNA G-Quadruplex Structures in Vitro and in Living Cells Using 19F NMR Spectroscopy. Nucleic Acids Res. 2017, 45, 5501–5511. [Google Scholar] [CrossRef] [PubMed]
  130. Ding, X.; Meng, S.; Zhou, J.; Yang, J.; Li, H.; Zhou, W. Translational Inhibition of α-Neurexin 2. Sci. Rep. 2020, 10, 3403. [Google Scholar] [CrossRef] [PubMed]
  131. Kumari, S.; Bugaut, A.; Huppert, J.L.; Balasubramanian, S. An RNA G-Quadruplex in the 5′ UTR of the NRAS Proto-Oncogene Modulates Translation. Nat. Chem. Biol. 2007, 3, 218–221. [Google Scholar] [CrossRef] [PubMed]
  132. Gomez, D.; Guédin, A.; Mergny, J.-L.; Salles, B.; Riou, J.-F.; Teulade-Fichou, M.-P.; Calsou, P. A G-Quadruplex Structure within the 5′-UTR of TRF2 mRNA Represses Translation in Human Cells. Nucleic Acids Res. 2010, 38, 7187–7198. [Google Scholar] [CrossRef] [PubMed]
  133. Kwok, C.K.; Ding, Y.; Shahid, S.; Assmann, S.M.; Bevilacqua, P.C. A Stable RNA G-Quadruplex within the 5′-UTR of Arabidopsis Thaliana ATR mRNA Inhibits Translation. Biochem. J. 2015, 467, 91–102. [Google Scholar] [CrossRef] [PubMed]
  134. Shahid, R.; Bugaut, A.; Balasubramanian, S. The BCL-2 5′ Untranslated Region Contains an RNA G-Quadruplex-Forming Motif That Modulates Protein Expression. Biochemistry 2010, 49, 8300–8306. [Google Scholar] [CrossRef] [PubMed]
  135. Lammich, S.; Kamp, F.; Wagner, J.; Nuscher, B.; Zilow, S.; Ludwig, A.-K.; Willem, M.; Haass, C. Translational Repression of the Disintegrin and Metalloprotease ADAM10 by a Stable G-Quadruplex Secondary Structure in Its 5′-Untranslated Region. J. Biol. Chem. 2011, 286, 45063–45072. [Google Scholar] [CrossRef]
  136. Weng, H.-Y.; Huang, H.-L.; Zhao, P.-P.; Zhou, H.; Qu, L.-H. Translational Repression of Cyclin D3 by a Stable G-Quadruplex in Its 5′ UTR: Implications for Cell Cycle Regulation. RNA Biol. 2012, 9, 1099–1109. [Google Scholar] [CrossRef] [PubMed]
  137. Morris, M.J.; Basu, S. An Unusually Stable G-Quadruplex within the 5′-UTR of the MT3 Matrix Metalloproteinase mRNA Represses Translation in Eukaryotic Cells. Biochemistry 2009, 48, 5313–5319. [Google Scholar] [CrossRef] [PubMed]
  138. Kumari, S.; Bugaut, A.; Balasubramanian, S. Position and Stability Are Determining Factors for Translation Repression by an RNA G-Quadruplex-Forming Sequence within the 5′ UTR of the NRAS Proto-Oncogene. Biochemistry 2008, 47, 12664–12669. [Google Scholar] [CrossRef]
  139. Hoque, M.E.; Mahendran, T.; Basu, S. Reversal of G-Quadruplexes’ Role in Translation Control When Present in the Context of an IRES. Biomolecules 2022, 12, 314. [Google Scholar] [CrossRef]
  140. Bhattacharyya, D.; Diamond, P.; Basu, S. An Independently Folding RNA G-Quadruplex Domain Directly Recruits the 40S Ribosomal Subunit. Biochemistry 2015, 54, 1879–1885. [Google Scholar] [CrossRef] [PubMed]
  141. Singha Roy, A.; Majumder, S.; Saha, P. Stable RNA G-Quadruplex in the 5′-UTR of Human cIAP1 mRNA Promotes Translation in an IRES-Independent Manner. Biochemistry 2024, 63, 475–486. [Google Scholar] [CrossRef]
  142. Agarwala, P.; Pandey, S.; Mapa, K.; Maiti, S. The G-Quadruplex Augments Translation in the 5′ Untranslated Region of Transforming Growth Factor Β2. Biochemistry 2013, 52, 1528–1538. [Google Scholar] [CrossRef] [PubMed]
  143. Agarwala, P.; Pandey, S.; Ekka, M.K.; Chakraborty, D.; Maiti, S. Combinatorial Role of Two G-Quadruplexes in 5′ UTR of Transforming Growth Factor Β2 (TGFβ2). Biochim. Biophys. Acta Gen. Subj. 2019, 1863, 129416. [Google Scholar] [CrossRef] [PubMed]
  144. Jodoin, R.; Carrier, J.C.; Rivard, N.; Bisaillon, M.; Perreault, J.-P. G-Quadruplex Located in the 5′UTR of the BAG-1 mRNA Affects Both Its Cap-Dependent and Cap-Independent Translation through Global Secondary Structure Maintenance. Nucleic Acids Res. 2019, 47, 10247–10266. [Google Scholar] [CrossRef] [PubMed]
  145. Liu, H.; Chu, Z.; Yang, X. A Key Molecular Regulator, RNA G-Quadruplex and Its Function in Plants. Front. Plant Sci. 2022, 13, 926953. [Google Scholar] [CrossRef] [PubMed]
  146. Dumetz, F.; Chow, E.Y.-C.; Harris, L.M.; Liew, S.W.; Jensen, A.; Umar, M.I.; Chung, B.; Chan, T.F.; Merrick, C.J.; Kwok, C.K. G-Quadruplex RNA Motifs Influence Gene Expression in the Malaria Parasite Plasmodium Falciparum. Nucleic Acids Res. 2021, 49, 12486–12501. [Google Scholar] [CrossRef] [PubMed]
  147. Varshney, D.; Cuesta, S.M.; Herdy, B.; Abdullah, U.B.; Tannahill, D.; Balasubramanian, S. RNA G-Quadruplex Structures Control Ribosomal Protein Production. Sci. Rep. 2021, 11, 22735. [Google Scholar] [CrossRef]
  148. Benhalevy, D.; Gupta, S.K.; Danan, C.H.; Ghosal, S.; Sun, H.-W.; Kazemier, H.G.; Paeschke, K.; Hafner, M.; Juranek, S.A. The Human CCHC-Type Zinc Finger Nucleic Acid-Binding Protein Binds G-Rich Elements in Target mRNA Coding Sequences and Promotes Translation. Cell Rep. 2017, 18, 2979–2990. [Google Scholar] [CrossRef] [PubMed]
  149. Herviou, P.; Le Bras, M.; Dumas, L.; Hieblot, C.; Gilhodes, J.; Cioci, G.; Hugnot, J.-P.; Ameadan, A.; Guillonneau, F.; Dassi, E.; et al. hnRNP H/F Drive RNA G-Quadruplex-Mediated Translation Linked to Genomic Instability and Therapy Resistance in Glioblastoma. Nat. Commun. 2020, 11, 2661. [Google Scholar] [CrossRef]
  150. Caterino, M.; Paeschke, K. Action and Function of Helicases on RNA G-Quadruplexes. Methods 2022, 204, 110–125. [Google Scholar] [CrossRef]
  151. Sauer, M.; Juranek, S.A.; Marks, J.; De Magis, A.; Kazemier, H.G.; Hilbig, D.; Benhalevy, D.; Wang, X.; Hafner, M.; Paeschke, K. DHX36 Prevents the Accumulation of Translationally Inactive mRNAs with G4-Structures in Untranslated Regions. Nat. Commun. 2019, 10, 2421. [Google Scholar] [CrossRef] [PubMed]
  152. Chen, X.; Xue, G.; Zhao, J.; Zhang, Y.; Zhang, S.; Wang, W.; Li, Y.; Yuan, J.; He, L.; Chan, C.Y.; et al. Lockd Promotes Myoblast Proliferation and Muscle Regeneration via Binding with DHX36 to Facilitate 5′ UTR rG4 Unwinding and Anp32e Translation. Cell Rep. 2022, 39, 110927. [Google Scholar] [CrossRef] [PubMed]
  153. Lyu, K.; Chen, S.-B.; Chow, E.Y.-C.; Zhao, H.; Yuan, J.-H.; Cai, M.; Shi, J.; Chan, T.-F.; Tan, J.-H.; Kwok, C.K. An RNA G-Quadruplex Structure within the ADAR 5′UTR Interacts with DHX36 Helicase to Regulate Translation. Angew. Chem. Int. Ed. Engl. 2022, 61, e202203553. [Google Scholar] [CrossRef] [PubMed]
  154. Wolfe, A.L.; Singh, K.; Zhong, Y.; Drewe, P.; Rajasekhar, V.K.; Sanghvi, V.R.; Mavrakis, K.J.; Jiang, M.; Roderick, J.E.; Van der Meulen, J.; et al. RNA G-Quadruplexes Cause eIF4A-Dependent Oncogene Translation in Cancer. Nature 2014, 513, 65–70. [Google Scholar] [CrossRef] [PubMed]
  155. Kharel, P.; Balaratnam, S.; Beals, N.; Basu, S. The Role of RNA G-quadruplexes in Human Diseases and Therapeutic Strategies. Wiley Interdiscip. Rev. RNA 2020, 11, e1568. [Google Scholar] [CrossRef] [PubMed]
  156. Wang, E.; Thombre, R.; Shah, Y.; Latanich, R.; Wang, J. G-Quadruplexes as Pathogenic Drivers in Neurodegenerative Disorders. Nucleic Acids Res. 2021, 49, 4816–4830. [Google Scholar] [CrossRef]
  157. Lee, D.S.M.; Ghanem, L.R.; Barash, Y. Integrative Analysis Reveals RNA G-Quadruplexes in UTRs Are Selectively Constrained and Enriched for Functional Associations. Nat. Commun. 2020, 11, 527. [Google Scholar] [CrossRef] [PubMed]
  158. Zeraati, M.; Moye, A.L.; Wong, J.W.H.; Perera, D.; Cowley, M.J.; Christ, D.U.; Bryan, T.M.; Dinger, M.E. Cancer-Associated Noncoding Mutations Affect RNA G-Quadruplex-Mediated Regulation of Gene Expression. Sci. Rep. 2017, 7, 708. [Google Scholar] [CrossRef] [PubMed]
  159. Jodoin, R.; Perreault, J.-P. G-Quadruplexes Formation in the 5′UTRs of mRNAs Associated with Colorectal Cancer Pathways. PLoS ONE 2018, 13, e0208363. [Google Scholar] [CrossRef] [PubMed]
  160. Cammas, A.; Desprairies, A.; Dassi, E.; Millevoi, S. The Shaping of mRNA Translation Plasticity by RNA G-Quadruplexes in Cancer Progression and Therapy Resistance. NAR Cancer 2024, 6, zcae025. [Google Scholar] [CrossRef] [PubMed]
  161. Umar, M.I.; Chan, C.-Y.; Kwok, C.K. Development of RNA G-Quadruplex (rG4)-Targeting l-RNA Aptamers by rG4-SELEX. Nat. Protoc. 2022, 17, 1385–1414. [Google Scholar] [CrossRef]
  162. Tao, Y.; Zheng, Y.; Zhai, Q.; Wei, D. Recent Advances in the Development of Small Molecules Targeting RNA G-Quadruplexes for Drug Discovery. Bioorg. Chem. 2021, 110, 104804. [Google Scholar] [CrossRef] [PubMed]
  163. Miglietta, G.; Cogoi, S.; Marinello, J.; Capranico, G.; Tikhomirov, A.S.; Shchekotikhin, A.; Xodo, L.E. RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation. J. Med. Chem. 2017, 60, 9448–9461. [Google Scholar] [CrossRef]
  164. Wang, X.-D.; Liu, Y.-S.; Hu, M.-H. Discovery of an Indolium-Based, Turn-on Fluorescent Ligand That Represses the Neuroblastoma RAS Expression by Targeting the 5′-UTR G-Quadruplex Structure. Sens. Actuators B Chem. 2024, 408, 135506. [Google Scholar] [CrossRef]
  165. Kharel, P.; Ivanov, P. RNA G-Quadruplexes and Stress: Emerging Mechanisms and Functions: Trends in Cell Biology. Trends Cell Biol. 2024, 34, 771–784. [Google Scholar] [CrossRef] [PubMed]
  166. Ma, Y.; Yang, Y.; Xin, J.; He, L.; Hu, Z.; Gao, T.; Pan, F.; Guo, Z. RNA G-Quadruplex within the 5′-UTR of FEN1 Regulates mRNA Stability under Oxidative Stress. Antioxidants 2023, 12, 276. [Google Scholar] [CrossRef] [PubMed]
  167. Roberts, L.; Wieden, H.-J. Viruses, IRESs, and a Universal Translation Initiation Mechanism. Biotechnol. Genet. Eng. Rev. 2018, 34, 60–75. [Google Scholar] [CrossRef] [PubMed]
  168. Zhao, J.; Li, Y.; Wang, C.; Zhang, H.; Zhang, H.; Jiang, B.; Guo, X.; Song, X. IRESbase: A Comprehensive Database of Experimentally Validated Internal Ribosome Entry Sites. Genom. Proteom. Bioinform. 2020, 18, 129–139. [Google Scholar] [CrossRef]
  169. Loughran, G.; Andreev, D.E.; Terenin, I.M.; Namy, O.; Mikl, M.; Yordanova, M.M.; Mcmanus, C.J.; Firth, A.E.; Atkins, J.F.; Fraser, C.S.; et al. Guidelines for Minimal Reporting Requirements, Design and Interpretation of Experiments Involving the Use of Eukaryotic Dual Gene Expression Reporters (MINDR). HAL 2024, hal:04395528. Available online: https://hal.science/hal-04395528/ (accessed on 20 February 2025).
  170. Shatsky, I.N.; Terenin, I.M.; Smirnova, V.V.; Andreev, D.E. Cap-Independent Translation: What’s in a Name? Trends Biochem. Sci. 2018, 43, 882–895. [Google Scholar] [CrossRef]
  171. Godet, A.-C.; David, F.; Hantelys, F.; Tatin, F.; Lacazette, E.; Garmy-Susini, B.; Prats, A.-C. IRES Trans-Acting Factors, Key Actors of the Stress Response. Int. J. Mol. Sci. 2019, 20, 924. [Google Scholar] [CrossRef]
  172. Yaman, I.; Fernandez, J.; Liu, H.; Caprara, M.; Komar, A.A.; Koromilas, A.E.; Zhou, L.; Snider, M.D.; Scheuner, D.; Kaufman, R.J.; et al. The Zipper Model of Translational Control: A Small Upstream ORF Is the Switch That Controls Structural Remodeling of an mRNA Leader. Cell 2003, 113, 519–531. [Google Scholar] [CrossRef] [PubMed]
  173. Bastide, A.; Karaa, Z.; Bornes, S.; Hieblot, C.; Lacazette, E.; Prats, H.; Touriol, C. An Upstream Open Reading Frame within an IRES Controls Expression of a Specific VEGF-A Isoform. Nucleic Acids Res. 2008, 36, 2434–2445. [Google Scholar] [CrossRef] [PubMed]
  174. Chen, T.-M.; Shih, Y.-H.; Tseng, J.T.; Lai, M.-C.; Wu, C.-H.; Li, Y.-H.; Tsai, S.-J.; Sun, H.S. Overexpression of FGF9 in Colon Cancer Cells Is Mediated by Hypoxia-Induced Translational Activation. Nucleic Acids Res. 2014, 42, 2932–2944. [Google Scholar] [CrossRef] [PubMed]
  175. Xue, S.; Tian, S.; Fujii, K.; Kladwang, W.; Das, R.; Barna, M. RNA Regulons in Hox 5′ UTRs Confer Ribosome Specificity to Gene Regulation. Nature 2015, 517, 33–38. [Google Scholar] [CrossRef] [PubMed]
  176. Akirtava, C.; May, G.E.; McManus, C.J. False-Positive IRESes from Hoxa9 and Other Genes Resulting from Errors in Mammalian 5′ UTR Annotations. Proc. Natl. Acad. Sci. USA 2022, 119, e2122170119. [Google Scholar] [CrossRef]
  177. Sun, H.; Li, K.; Liu, C.; Yi, C. Regulation and Functions of Non-m6A mRNA Modifications. Nat. Rev. Mol. Cell Biol. 2023, 24, 714–731. [Google Scholar] [CrossRef]
  178. Ramanathan, A.; Robb, G.B.; Chan, S.-H. mRNA Capping: Biological Functions and Applications. Nucleic Acids Res. 2016, 44, 7511–7526. [Google Scholar] [CrossRef] [PubMed]
  179. Mancini, F.; Cahova, H. The Mysterious World of Non-Canonical Caps—What We Know and Why We Need New Sequencing Techniques. Chembiochem 2024, 26, e202400604. [Google Scholar] [CrossRef] [PubMed]
  180. Malbec, L.; Zhang, T.; Chen, Y.-S.; Zhang, Y.; Sun, B.-F.; Shi, B.-Y.; Zhao, Y.-L.; Yang, Y.; Yang, Y.-G. Dynamic Methylome of Internal mRNA N7-Methylguanosine and Its Regulatory Role in Translation. Cell Res. 2019, 29, 927–941. [Google Scholar] [CrossRef] [PubMed]
  181. Zhang, L.-S.; Liu, C.; Ma, H.; Dai, Q.; Sun, H.-L.; Luo, G.; Zhang, Z.; Zhang, L.; Hu, L.; Dong, X.; et al. Transcriptome-Wide Mapping of Internal N7-Methylguanosine Methylome in Mammalian mRNA. Mol. Cell 2019, 74, 1304–1316.e8. [Google Scholar] [CrossRef] [PubMed]
  182. Cesaro, B.; Tarullo, M.; Fatica, A. Regulation of Gene Expression by m6Am RNA Modification. Int. J. Mol. Sci. 2023, 24, 2277. [Google Scholar] [CrossRef] [PubMed]
  183. Boulias, K.; Toczydłowska-Socha, D.; Hawley, B.R.; Liberman, N.; Takashima, K.; Zaccara, S.; Guez, T.; Vasseur, J.-J.; Debart, F.; Aravind, L.; et al. Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome. Mol. Cell 2019, 75, 631–643.e8. [Google Scholar] [CrossRef] [PubMed]
  184. Wang, S.; Lv, W.; Li, T.; Zhang, S.; Wang, H.; Li, X.; Wang, L.; Ma, D.; Zang, Y.; Shen, J.; et al. Dynamic Regulation and Functions of mRNA m6A Modification. Cancer Cell Int. 2022, 22, 48. [Google Scholar] [CrossRef]
  185. Meyer, K.D.; Patil, D.P.; Zhou, J.; Zinoviev, A.; Skabkin, M.A.; Elemento, O.; Pestova, T.V.; Qian, S.-B.; Jaffrey, S.R. 5′ UTR m6A Promotes Cap-Independent Translation. Cell 2015, 163, 999–1010. [Google Scholar] [CrossRef] [PubMed]
  186. Coots, R.A.; Liu, X.-M.; Mao, Y.; Dong, L.; Zhou, J.; Wan, J.; Zhang, X.; Qian, S.-B. m6A Facilitates eIF4F-Independent mRNA Translation. Mol. Cell 2017, 68, 504–514.e7. [Google Scholar] [CrossRef]
  187. Chang, G.; Shi, L.; Ye, Y.; Shi, H.; Zeng, L.; Tiwary, S.; Huse, J.T.; Huo, L.; Ma, L.; Ma, Y.; et al. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. Cancer Cell 2020, 38, 857–871.e7. [Google Scholar] [CrossRef]
  188. Prats, A.-C.; David, F.; Diallo, L.H.; Roussel, E.; Tatin, F.; Garmy-Susini, B.; Lacazette, E. Circular RNA, the Key for Translation. Int. J. Mol. Sci. 2020, 21, 8591. [Google Scholar] [CrossRef] [PubMed]
  189. Meyer, K.D. m6A-Mediated Translation Regulation. Biochim. Biophys. Acta Gene Regul. Mech. 2019, 1862, 301–309. [Google Scholar] [CrossRef] [PubMed]
  190. Zhou, H.; Kimsey, I.J.; Nikolova, E.N.; Sathyamoorthy, B.; Grazioli, G.; McSally, J.; Bai, T.; Wunderlich, C.H.; Kreutz, C.; Andricioaei, I.; et al. m1A and m1G Disrupt A-RNA Structure through the Intrinsic Instability of Hoogsteen Base Pairs. Nat. Struct. Mol. Biol. 2016, 23, 803–810. [Google Scholar] [CrossRef] [PubMed]
  191. Li, X.; Xiong, X.; Zhang, M.; Wang, K.; Chen, Y.; Zhou, J.; Mao, Y.; Lv, J.; Yi, D.; Chen, X.-W.; et al. Base-Resolution Mapping Reveals Distinct m1A Methylome in Nuclear- and Mitochondrial-Encoded Transcripts. Mol. Cell 2017, 68, 993–1005.e9. [Google Scholar] [CrossRef]
  192. Li, X.; Xiong, X.; Wang, K.; Wang, L.; Shu, X.; Ma, S.; Yi, C. Transcriptome-Wide Mapping Reveals Reversible and Dynamic N1-Methyladenosine Methylome. Nat. Chem. Biol. 2016, 12, 311–316. [Google Scholar] [CrossRef]
  193. Dominissini, D.; Rechavi, G. Loud and Clear Epitranscriptomic m1A Signals: Now in Single-Base Resolution. Mol. Cell 2017, 68, 825–826. [Google Scholar] [CrossRef]
  194. Dominissini, D.; Nachtergaele, S.; Moshitch-Moshkovitz, S.; Peer, E.; Kol, N.; Ben-Haim, M.S.; Dai, Q.; Di Segni, A.; Salmon-Divon, M.; Clark, W.C.; et al. The Dynamic N1-Methyladenosine Methylome in Eukaryotic Messenger RNA. Nature 2016, 530, 441–446. [Google Scholar] [CrossRef] [PubMed]
  195. Schumann, U.; Zhang, H.-N.; Sibbritt, T.; Pan, A.; Horvath, A.; Gross, S.; Clark, S.J.; Yang, L.; Preiss, T. Multiple Links between 5-Methylcytosine Content of mRNA and Translation. BMC Biol. 2020, 18, 40. [Google Scholar] [CrossRef] [PubMed]
  196. Huang, T.; Chen, W.; Liu, J.; Gu, N.; Zhang, R. Genome-Wide Identification of mRNA 5-Methylcytosine in Mammals. Nat. Struct. Mol. Biol. 2019, 26, 380–388. [Google Scholar] [CrossRef] [PubMed]
  197. Mendoza, H.G.; Beal, P.A. Structural and Functional Effects of Inosine Modification in mRNA. RNA 2024, 30, 512–520. [Google Scholar] [CrossRef]
  198. Hagen, T.; Laski, A.; Brümmer, A.; Pruška, A.; Schlösser, V.; Cléry, A.; Allain, F.H.-T.; Zenobi, R.; Bergmann, S.; Hall, J. Inosine Substitutions in RNA Activate Latent G-Quadruplexes. J. Am. Chem. Soc. 2021, 143, 15120–15130. [Google Scholar] [CrossRef]
  199. Arango, D.; Sturgill, D.; Alhusaini, N.; Dillman, A.A.; Sweet, T.J.; Hanson, G.; Hosogane, M.; Sinclair, W.R.; Nanan, K.K.; Mandler, M.D.; et al. Acetylation of Cytidine in mRNA Promotes Translation Efficiency. Cell 2018, 175, 1872–1886.e24. [Google Scholar] [CrossRef] [PubMed]
  200. Arango, D.; Sturgill, D.; Yang, R.; Kanai, T.; Bauer, P.; Roy, J.; Wang, Z.; Hosogane, M.; Schiffers, S.; Oberdoerffer, S. Direct Epitranscriptomic Regulation of Mammalian Translation Initiation through N4-Acetylcytidine. Mol. Cell 2022, 82, 2797–2814.e11. [Google Scholar] [CrossRef] [PubMed]
  201. Sas-Chen, A.; Thomas, J.M.; Matzov, D.; Taoka, M.; Nance, K.D.; Nir, R.; Bryson, K.M.; Shachar, R.; Liman, G.L.S.; Burkhart, B.W.; et al. Dynamic RNA Acetylation Revealed by Quantitative Cross-Evolutionary Mapping. Nature 2020, 583, 638–643. [Google Scholar] [CrossRef] [PubMed]
  202. Li, K.; Peng, J.; Yi, C. Sequencing Methods and Functional Decoding of mRNA Modifications. Fundam. Res. 2023, 3, 738–748. [Google Scholar] [CrossRef]
  203. Lee, E.K.; Kim, W.; Tominaga, K.; Martindale, J.L.; Yang, X.; Subaran, S.S.; Carlson, O.D.; Mercken, E.M.; Kulkarni, R.N.; Akamatsu, W.; et al. RNA-Binding Protein HuD Controls Insulin Translation. Mol. Cell 2012, 45, 826–835. [Google Scholar] [CrossRef] [PubMed]
  204. Panda, A.C.; Sahu, I.; Kulkarni, S.D.; Martindale, J.L.; Abdelmohsen, K.; Vindu, A.; Joseph, J.; Gorospe, M.; Seshadri, V. miR-196b-Mediated Translation Regulation of Mouse Insulin2 via the 5′UTR. PLoS ONE 2014, 9, e101084. [Google Scholar] [CrossRef] [PubMed]
  205. Kim, J.; Park, R.Y.; Chen, J.-K.; Kim, J.; Jeong, S.; Ohn, T. Splicing Factor SRSF3 Represses the Translation of Programmed Cell Death 4 mRNA by Associating with the 5′-UTR Region. Cell Death Differ. 2014, 21, 481–490. [Google Scholar] [CrossRef] [PubMed]
  206. Schneider-Lunitz, V.; Ruiz-Orera, J.; Hubner, N.; Heesch, S. van Multifunctional RNA-Binding Proteins Influence mRNA Abundance and Translational Efficiency of Distinct Sets of Target Genes. PLoS Comput. Biol. 2021, 17, e1009658. [Google Scholar] [CrossRef] [PubMed]
  207. Ben-Oz, B.M.; Machour, F.E.; Nicola, M. A Dual Role of RBM42 in Modulating Splicing and Translation of CDKN1A/P21 during DNA Damage Response. Nat. Commun. 2023, 14, 7628. [Google Scholar] [CrossRef]
  208. Carrieri, C.; Cimatti, L.; Biagioli, M.; Beugnet, A.; Zucchelli, S.; Fedele, S.; Pesce, E.; Ferrer, I.; Collavin, L.; Santoro, C.; et al. Long Non-Coding Antisense RNA Controls Uchl1 Translation through an Embedded SINEB2 Repeat. Nature 2012, 491, 454–457. [Google Scholar] [CrossRef]
  209. Schein, A.; Zucchelli, S.; Kauppinen, S.; Gustincich, S.; Carninci, P. Identification of Antisense Long Noncoding RNAs That Function as SINEUPs in Human Cells. Sci. Rep. 2016, 6, 33605. [Google Scholar] [CrossRef]
  210. Tran, N.; Su, H.; Khodadadi-Jamayran, A.; Lin, S.; Zhang, L.; Zhou, D.; Pawlik, K.M.; Townes, T.M.; Chen, Y.; Mulloy, J.C.; et al. The AS-RBM15 lncRNA Enhances RBM15 Protein Translation during Megakaryocyte Differentiation. EMBO Rep. 2016, 17, 887–900. [Google Scholar] [CrossRef] [PubMed]
  211. Toki, N.; Takahashi, H.; Sharma, H.; Valentine, M.N.Z.; Rahman, F.-U.M.; Zucchelli, S.; Gustincich, S.; Carninci, P. SINEUP Long Non-Coding RNA Acts via PTBP1 and HNRNPK to Promote Translational Initiation Assemblies. Nucleic Acids Res. 2020, 48, 11626–11644. [Google Scholar] [CrossRef]
  212. Pierattini, B.; D’Agostino, S.; Bon, C.; Peruzzo, O.; Alendar, A.; Codino, A.; Ros, G.; Persichetti, F.; Sanges, R.; Carninci, P.; et al. SINEUP Non-Coding RNA Activity Depends on Specific N6-Methyladenosine Nucleotides. Mol. Ther. Nucleic Acids 2023, 32, 402–414. [Google Scholar] [CrossRef] [PubMed]
  213. Sharma, H.; Valentine, M.; Toki, N.; Nishiyori Sueki, H.; Gustincich, S.; Takahashi, H.; Carninci, P. Decryption of Sequence, Structure, and Functional Features of SINE Repeat Elements in SINEUP Non-Coding RNA-Mediated Post-Transcriptional Gene Regulation. Nat. Commun. 2024, 15, 1400. [Google Scholar] [CrossRef]
  214. D’Agostino, S.; Tettey-Matey, A.; Volpe, M.; Pierattini, B.; Ansaloni, F.; Lau, P.; Bon, C.; Peruzzo, O.; Braccia, C.; Armirotti, A.; et al. Internal Ribosome Entry Sites Act as Effector Domain in Linear and Circular Antisense Long Non-Coding SINEUP RNAs. bioRxiv 2023, 2023.05.25.542260. [Google Scholar]
  215. Valentini, P.; Pierattini, B.; Zacco, E.; Mangoni, D.; Espinoza, S.; Webster, N.A.; Andrews, B.; Carninci, P.; Tartaglia, G.G.; Pandolfini, L.; et al. Towards SINEUP-Based Therapeutics: Design of an in Vitro Synthesized SINEUP RNA. Mol. Ther. Nucleic Acids 2022, 27, 1092–1102. [Google Scholar] [CrossRef]
  216. Bon, C.; Luffarelli, R.; Russo, R.; Fortuni, S.; Pierattini, B.; Santulli, C.; Fimiani, C.; Persichetti, F.; Cotella, D.; Mallamaci, A.; et al. SINEUP Non-Coding RNAs Rescue Defective Frataxin Expression and Activity in a Cellular Model of Friedreich’s Ataxia. Nucleic Acids Res. 2019, 47, 10728–10743. [Google Scholar] [CrossRef] [PubMed]
  217. Zucchelli, S.; Fasolo, F.; Russo, R.; Cimatti, L.; Patrucco, L.; Takahashi, H.; Jones, M.H.; Santoro, C.; Sblattero, D.; Cotella, D.; et al. SINEUPs Are Modular Antisense Long Non-Coding RNAs That Increase Synthesis of Target Proteins in Cells. Front. Cell. Neurosci. 2015, 9, 174. [Google Scholar] [CrossRef]
Figure 1. The canonical mechanism of translation initiation is illustrated on the left. This process includes the following stages: mRNA activation, the formation of the scanning 48S preinitiation complex, the recognition of the start codon, and the recruitment of the 60S subunit. On the right is a depiction of non-canonical translation initiation mechanisms. These include the use of non-canonical factors, various cap-independent mechanisms, and the translation of mRNA with very short 5′ UTRs.
Figure 1. The canonical mechanism of translation initiation is illustrated on the left. This process includes the following stages: mRNA activation, the formation of the scanning 48S preinitiation complex, the recognition of the start codon, and the recruitment of the 60S subunit. On the right is a depiction of non-canonical translation initiation mechanisms. These include the use of non-canonical factors, various cap-independent mechanisms, and the translation of mRNA with very short 5′ UTRs.
Ijms 26 01979 g001
Figure 2. LARP1-mediated regulation of TOP mRNA translation. (A) The La-module of LARP1 binds the polyadenylated tail of mRNA and PABP independently of mTORC1. The DM15 domain of LARP1 is inactivated by phosphorylation, thus enabling the access of translation initiation factors to the 5′ end of TOP mRNA and its active translation. (B) The DM15 domain of LARP1, which is activated by dephosphorylation, blocks the assembly of the initiation complex through interaction with the TOP motif. This results in the TOP-mediated repression of mRNA translation under nutrient-deficient conditions.
Figure 2. LARP1-mediated regulation of TOP mRNA translation. (A) The La-module of LARP1 binds the polyadenylated tail of mRNA and PABP independently of mTORC1. The DM15 domain of LARP1 is inactivated by phosphorylation, thus enabling the access of translation initiation factors to the 5′ end of TOP mRNA and its active translation. (B) The DM15 domain of LARP1, which is activated by dephosphorylation, blocks the assembly of the initiation complex through interaction with the TOP motif. This results in the TOP-mediated repression of mRNA translation under nutrient-deficient conditions.
Ijms 26 01979 g002
Figure 3. Regulation of translation by upstream ORF and start codons. The figure illustrates the characteristics of upstream ORFs (uORFs) that define their properties. Firstly, the location of the upstream start codon relative to the CDS and the resulting uORF length should be considered. The presence of an in-frame upstream start codon without an in-frame stop codon results in extended proteoform being translated. In all the other cases, uORFs are present. They can be located within 5′ UTR, or overlap the CDS (referred to as overlapping uORFs). The 5′ UTR can also contain start–stop regulatory elements. Secondly, the nucleotide context of the start codon, which determines the probability of translation initiation, and the distance to the CDS, which determines the probability of translation reinitiation at the CDS, also play a determining role. Moreover, uORFs can induce translation ribosome arrest in the case of a rare codon, a difficult-to-pass amino acid motif, or ligand binding by a nascent peptide. Ribosome arrest at the 5′ UTR can lead to mRNA degradation via the nonsense-mediated decay (NMD) pathway, stimulation of cap-independent translation, and repression of the CDS translation. uORFs may also encode a functional peptide that is part of the CDS product complex or has independent functions.
Figure 3. Regulation of translation by upstream ORF and start codons. The figure illustrates the characteristics of upstream ORFs (uORFs) that define their properties. Firstly, the location of the upstream start codon relative to the CDS and the resulting uORF length should be considered. The presence of an in-frame upstream start codon without an in-frame stop codon results in extended proteoform being translated. In all the other cases, uORFs are present. They can be located within 5′ UTR, or overlap the CDS (referred to as overlapping uORFs). The 5′ UTR can also contain start–stop regulatory elements. Secondly, the nucleotide context of the start codon, which determines the probability of translation initiation, and the distance to the CDS, which determines the probability of translation reinitiation at the CDS, also play a determining role. Moreover, uORFs can induce translation ribosome arrest in the case of a rare codon, a difficult-to-pass amino acid motif, or ligand binding by a nascent peptide. Ribosome arrest at the 5′ UTR can lead to mRNA degradation via the nonsense-mediated decay (NMD) pathway, stimulation of cap-independent translation, and repression of the CDS translation. uORFs may also encode a functional peptide that is part of the CDS product complex or has independent functions.
Ijms 26 01979 g003
Figure 4. Regulation of translation by secondary structures. (A) The structure of canonical and non-canonical rG4. (B) The regulation of translation by rG4: Stable rG4 in the 5′ cap region or upstream of the start codon suppresses translation. Conversely, the presence of rG4 downstream of the start codon leads to a ribosome queue and promotes translation at the upstream codon. It is also worth noting that rG4 can be stabilized by RBP or unwound by helicases. (C) Translation can also be modulated by a pseudoknot: The translation of human IFN-γ mRNA containing a pseudoknot in the 5′ UTR is regulated by a protein kinase R (PKR) feedback loop. IFN-γ activates PKR via the pseudoknot, resulting in the increased phosphorylation of eIF2α and decreased IFN-γ translation. (D) A hairpin downstream of the start codon can promote translation by increasing the time for AUG recognition by the ribosome. Conversely, the presence of a stabilized hairpin may result in translation suppression, as observed in the iron-responsive element (IRE) located in the 5′ UTR of ferritin. This hairpin serves as the binding site for the iron-regulatory proteins IRP1/2, which stabilize it under iron-deficient conditions. Hairpins have also been observed to regulate non-canonical cap-dependent translation by binding eIF3 directly. The deletion of the binding site in the described mRNA examples, JUN and BTG1, have opposite effects on translation. (E) IRES regulation: The functionality of the IRES element depends on ITAF, rG4, and uORF. ITAFs modulate the conformation of IRES, typically resulting in its activation. RBP or lncRNA can act as ITAFs. rG4 can play a structural role in IRES, particularly in critical regions such as the 40S binding domain. It has been proposed that rG4 may facilitate the interaction of IRES with ITAF. The translation of an uORF upstream of IRES has been shown to suppress its activity. The translation of uORFs that are part of the IRES has been demonstrated to activate and repress it, promoting or inhibiting the formation of an active structure, respectively.
Figure 4. Regulation of translation by secondary structures. (A) The structure of canonical and non-canonical rG4. (B) The regulation of translation by rG4: Stable rG4 in the 5′ cap region or upstream of the start codon suppresses translation. Conversely, the presence of rG4 downstream of the start codon leads to a ribosome queue and promotes translation at the upstream codon. It is also worth noting that rG4 can be stabilized by RBP or unwound by helicases. (C) Translation can also be modulated by a pseudoknot: The translation of human IFN-γ mRNA containing a pseudoknot in the 5′ UTR is regulated by a protein kinase R (PKR) feedback loop. IFN-γ activates PKR via the pseudoknot, resulting in the increased phosphorylation of eIF2α and decreased IFN-γ translation. (D) A hairpin downstream of the start codon can promote translation by increasing the time for AUG recognition by the ribosome. Conversely, the presence of a stabilized hairpin may result in translation suppression, as observed in the iron-responsive element (IRE) located in the 5′ UTR of ferritin. This hairpin serves as the binding site for the iron-regulatory proteins IRP1/2, which stabilize it under iron-deficient conditions. Hairpins have also been observed to regulate non-canonical cap-dependent translation by binding eIF3 directly. The deletion of the binding site in the described mRNA examples, JUN and BTG1, have opposite effects on translation. (E) IRES regulation: The functionality of the IRES element depends on ITAF, rG4, and uORF. ITAFs modulate the conformation of IRES, typically resulting in its activation. RBP or lncRNA can act as ITAFs. rG4 can play a structural role in IRES, particularly in critical regions such as the 40S binding domain. It has been proposed that rG4 may facilitate the interaction of IRES with ITAF. The translation of an uORF upstream of IRES has been shown to suppress its activity. The translation of uORFs that are part of the IRES has been demonstrated to activate and repress it, promoting or inhibiting the formation of an active structure, respectively.
Ijms 26 01979 g004
Figure 5. Diversity of modifications in the 5′ UTR of mRNA and their functions. The 5′ UTR and eukaryotic cap variants exhibit a variety of modifications. m6Am is found in the nucleotide following the cap. Inosine is a potential source of latent rG4, while m1A has been linked to the destabilization of secondary structures. m6A has been shown to contribute to non-canonical translation initiation. m5C and internal m7G have been detected in the 5′ UTR of eukaryotes, though their specific functions remain to be elucidated. Ac4C is believed to promote translation at the CUG start codon and repress translation at position −1 of the AUG.
Figure 5. Diversity of modifications in the 5′ UTR of mRNA and their functions. The 5′ UTR and eukaryotic cap variants exhibit a variety of modifications. m6Am is found in the nucleotide following the cap. Inosine is a potential source of latent rG4, while m1A has been linked to the destabilization of secondary structures. m6A has been shown to contribute to non-canonical translation initiation. m5C and internal m7G have been detected in the 5′ UTR of eukaryotes, though their specific functions remain to be elucidated. Ac4C is believed to promote translation at the CUG start codon and repress translation at position −1 of the AUG.
Ijms 26 01979 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Razumova, E.; Makariuk, A.; Dontsova, O.; Shepelev, N.; Rubtsova, M. Structural Features of 5′ Untranslated Region in Translational Control of Eukaryotes. Int. J. Mol. Sci. 2025, 26, 1979. https://doi.org/10.3390/ijms26051979

AMA Style

Razumova E, Makariuk A, Dontsova O, Shepelev N, Rubtsova M. Structural Features of 5′ Untranslated Region in Translational Control of Eukaryotes. International Journal of Molecular Sciences. 2025; 26(5):1979. https://doi.org/10.3390/ijms26051979

Chicago/Turabian Style

Razumova, Elizaveta, Aleksandr Makariuk, Olga Dontsova, Nikita Shepelev, and Maria Rubtsova. 2025. "Structural Features of 5′ Untranslated Region in Translational Control of Eukaryotes" International Journal of Molecular Sciences 26, no. 5: 1979. https://doi.org/10.3390/ijms26051979

APA Style

Razumova, E., Makariuk, A., Dontsova, O., Shepelev, N., & Rubtsova, M. (2025). Structural Features of 5′ Untranslated Region in Translational Control of Eukaryotes. International Journal of Molecular Sciences, 26(5), 1979. https://doi.org/10.3390/ijms26051979

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop